"adrenergic blocking agent amides. this classification denotes adrenergic blocking agents made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. . "
"adrenergic blocking agent amides. this classification denotes adrenergic blocking agents made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. ancarolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c18h24n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 00eed65inl, chemically known as (r,s)-2-(3-(tert-butylamino)-2-hydroxypropoxy-2-furanilid but generally known as ancarolol, which bears us nih compound identifier 170339. european medicines agency schedules ancarolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05506mig. the term ancarolol is an international non-proprietary name. ancarolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ancarolol under hs 29321900 and sitc 51569. as of q4 2014, ancarolol remains the us fda preferred term for this commodity. ancarolol bears us nlm identifiers umls id c2346780 and nci concept code c73014. smiles: oc(cnc(c)(c)c)coc1c(nc(=o)c2occc2)cccc1.. "
"adrenergic blocking agent amides. this classification denotes adrenergic blocking agents made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. cetamolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c16h26n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, z0vd1633o8 chemically known as acetamide, 2-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenoxy)-n-methyl-, (+/-)- but generally known as cetamolol, which bears us nih compound identifier 53698. european medicines agency schedules cetamolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07446mig. the term cetamolol is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28. ). most nations schedule cetamolol under hs 29242995 and sitc 51479. as of q4 2014, cetamolol remains the us fda preferred term for this commodity. cetamolol bears us nlm identifiers umls id c0055143 and nci concept code c81659. smiles: cc(c)(c)ncc(coc1=cc=cc=c1occ(=o)nc)o.. "
"adrenergic blocking agent amides. this classification denotes adrenergic blocking agents made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. indoramin. this classification denotes a beta-adrenergic blocking agent with the molecular formula c22h25n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0z802hmy7h, chemically known as benzamide, n-(1-(2-indol-3-ylethyl)-4-piperidyl)- but generally known as indoramin, which bears us nih compound identifier 33625. european medicines agency schedules indoramin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08184mig. the term indoramin is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules indoramin in its anatomical therapeutic chemical (atc) classification. indoramin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule indoramin under hs 29333999 and sitc 51574. as of q4 2014, indoramin remains the us fda preferred term for this commodity. indoramin bears us nlm identifiers umls id c0021252 and nci concept code c65916. smiles: o=c(nc1ccn(cc1)ccc1c2c([nh]c1)cccc2)c1ccccc1.. "
"adrenergic blocking agent amides. this classification denotes adrenergic blocking agents made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. cetamolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c16h26n2o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5unk5c6qm5, chemically known as 2-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenoxy)-n-methylacetamide monohydrochloride but more generally known as cetamolol hydrochloride, which bears us nih compound identifier 53697. most nations, for tariff and trade purposes, schedule cetamolol hydrochloride under hs 29242995 and sitc 51479. as of q4 2014, cetamolol hydrochloride remains us fdas preferred term for this commodity. cetamolol hydrochloride bears us nlm identifiers umls id c2825713 and nci concept code c81652. smiles: cc(c)(c)ncc(coc1ccccc1occ(=o)nc)o.cl.. "
"adrenergic blocking agent amides. this classification denotes adrenergic blocking agents made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. indoramin hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c22h25n3o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dq0z3k8w92, chemically known as benzamide, n-(1-(2-(1h-indol-3-yl)ethyl)-4-piperidinyl)-, monohydrochloride but more generally known as indoramin hydrochloride, which bears us nih compound identifier 38102. european medicines agency schedules indoramin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02679mig. most nations, for tariff and trade purposes, schedule indoramin hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, indoramin hydrochloride remains us fdas preferred term for this commodity. smiles: c1ccc(cc1)c(=o)nc2ccn(cc2)ccc3c[nh]c4c3cccc4.cl.. "
"adrenergic blocking agent amines. this classification denotes adrenergic blocking agents made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. . "
"adrenergic blocking agent amines. this classification denotes adrenergic blocking agents made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. phenoxybenzamine. this classification denotes a carcinogenic aromatic amine and alpha-adrenergic blocking agent with the molecular formula c18h22clno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0ttz664r7z, chemically known as n-(2-chloroethyl)-n-(1-methyl-2-phenoxyethyl)benzylamine, hydrochloride but generally known as phenoxybenzamine, which bears us nih compound identifier 4768. european medicines agency schedules phenoxybenzamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09778mig. the term phenoxybenzamine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules phenoxybenzamine in its anatomical therapeutic chemical (atc) classification. phenoxybenzamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule phenoxybenzamine under hs 29221980 and sitc 51461. as of q4 2014, phenoxybenzamine remains the us fda preferred term for this commodity. phenoxybenzamine bears us nlm identifiers umls id c0031441 and nci concept code c62065. smiles: clccn(c(coc1ccccc1)c)cc1ccccc1.. "
"adrenergic blocking agent amines. this classification denotes adrenergic blocking agents made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. butaxamine or butoxamine. this classification denotes a beta-adrenergic blocking agent with the molecular formula c15h25no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0nm31m53pw, chemically known as benzenemethanol, .alpha.-(1-((1,1-dimethylethyl)amino)ethyl)-2,5-dimethoxy-, (r*,s*)-, (+/-)- but generally known as butoxamine, which bears us nih compound identifier 134495. smiles: cc(c(c1=c(c=cc(=c1)oc)oc)o)nc(c)(c)c.. "
"adrenergic blocking agent amines. this classification denotes adrenergic blocking agents made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. phenoxybenzamine hydrochloride. this classification denotes an adrenergic alpha-antagonist, antihypertensive agent, and vasodilator agent with the molecular formula c18h22clno.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x1ieg24ohl, chemically known as n-(2-chloroethyl)-n-(1-methyl-2-phenoxyethyl)benzylamine, hydrochloride but more generally known as phenoxybenzamine hydrochloride, which bears us nih compound identifier 4768. european medicines agency schedules phenoxybenzamine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03761mig. most nations, for tariff and trade purposes, schedule phenoxybenzamine hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, phenoxybenzamine hydrochloride remains us fdas preferred term for this commodity. phenoxybenzamine hydrochloride bears us nlm identifiers umls id c0701367 and nci concept code c44435. smiles: cc(coc1ccccc1)n(cccl)cc2ccccc2.cl.. "
"adrenergic blocking agent amino alcohols and aminoquinolines and benzopyrans and bradykinin/analogs and derivatives. this classification denotes adrenergic blocking agent drugs made from or based in part on amino alcohols, aminoquinolines, benzopyrans, or bradykinin/analogs & derivatives. . "
"adrenergic blocking agent amino alcohols and aminoquinolines and benzopyrans and bradykinin/analogs and derivatives. this classification denotes adrenergic blocking agent drugs made from or based in part on amino alcohols, aminoquinolines, benzopyrans, or bradykinin/analogs & derivatives. arnolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c14h23no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 98hs077rup, chemically known as 2-butanol, 3-amino-1-(4-(2-methoxyethyl)phenoxy)-3-methyl- but generally known as arnolol, which bears us nih compound identifier 65653. european medicines agency schedules arnolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05565mig. the term arnolol is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). arnolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule arnolol under hs 29221980 and sitc 51461. as of q4 2014, arnolol remains the us fda preferred term for this commodity. arnolol bears us nlm identifiers umls id c0641873 and nci concept code c73015. smiles: oc(c(n)(c)c)coc1ccc(ccoc)cc1.. "
"adrenergic blocking agent amino alcohols and aminoquinolines and benzopyrans and bradykinin/analogs and derivatives. this classification denotes adrenergic blocking agent drugs made from or based in part on amino alcohols, aminoquinolines, benzopyrans, or bradykinin/analogs & derivatives. abanoquil. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c22h25n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f738mwy53l, chemically known as 4-quinolinamine, 2-(3,4-dihydro-6,7-dimethoxy-2(1h)-isoquinolinyl)-6,7-dimethoxy-, monomethanesulfonate but generally known as abanoquil, which bears us nih compound identifier 164088. abanoquil also appears in mesilate or mesylate form. european medicines agency schedules abanoquil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07358mig. the term abanoquil is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). abanoquil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule abanoquil under hs 29334990 and sitc 51575. as of q4 2014, abanoquil remains the us fda preferred term for this commodity. abanoquil bears us nlm identifiers umls id c0165215 and nci concept code c72566. smiles: s(=o)(=o)(o)c.o(c1cc2ccn(cc2cc1oc)c1nc2c(c(n)c1)cc(oc)c(oc)c2)c.. "
"adrenergic blocking agent amino alcohols and aminoquinolines and benzopyrans and bradykinin/analogs and derivatives. this classification denotes adrenergic blocking agent drugs made from or based in part on amino alcohols, aminoquinolines, benzopyrans, or bradykinin/analogs & derivatives. nebivolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c22h25f2no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 030y90569u, chemically known as 2h-1-benzopyran-2-methanol, alpha,alpha-(iminobis(methylene))bis(6-fluoro-3,4-dihydro- but generally known as nebivolol, which bears us nih compound identifier 71301. european medicines agency schedules nebivolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09175mig. the term nebivolol is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules nebivolol in its anatomical therapeutic chemical (atc) classification. nebivolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nebivolol under hs 29329985 and sitc 51569. as of q4 2014, nebivolol remains the us fda preferred term for this commodity. nebivolol bears us nlm identifiers umls id c0068475 and nci concept code c66221. smiles: fc1cc2ccc(oc2cc1)c(o)cncc(o)c1oc2c(cc1)cc(f)cc2.. "
"adrenergic blocking agent amino alcohols and aminoquinolines and benzopyrans and bradykinin/analogs and derivatives. this classification denotes adrenergic blocking agent drugs made from or based in part on amino alcohols, aminoquinolines, benzopyrans, or bradykinin/analogs & derivatives. icatibant. this classification denotes an adrenergic beta-antagonist, non-steroidal anti-inflammatory agent, and antiasthmatic agent with the molecular formula c59h89n19o13s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7pg89g35q7, chemically known as l-arginine, d-arginyl-l-arginyl-l-prolyl-trans-4-hydroxy-l-prolylglycyl-3-(2-thienyl)-l-alanyl-l-seryl-d-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-l-(2alpha,3abeta,7abeta)-octahydro-1h-indole-2-carbonyl- but generally known as icatibant, which bears us nih compound identifier 71364. european medicines agency schedules icatibant in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08104mig. world health organization schedules icatibant in its anatomical therapeutic chemical (atc) classification. icatibant is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule icatibant under hs 29349990 and sitc 51579. as of q4 2014, icatibant remains the us fda preferred term for this commodity. icatibant bears us nlm identifiers umls id c0246269 and nci concept code c98883. smiles: s1c(cc(nc(=o)cnc(=o)c2n(cc(o)c2)c(=o)c2n(ccc2)c(=o)c(nc(=o)c(n)ccc/n=c(/n)n)ccc/n=c(/n)n)c(=o)nc(c(=o)n2c(c(=o)n3c4c(cc3c(=o)nc(ccc/n=c(/n)n)c(=o)o)cccc4)cc3c(c2)cccc3)co)ccc1.. "
"adrenergic blocking agent amino alcohols and aminoquinolines and benzopyrans and bradykinin/analogs and derivatives. this classification denotes adrenergic blocking agent drugs made from or based in part on amino alcohols, aminoquinolines, benzopyrans, or bradykinin/analogs & derivatives. icatibant acetate. this classification denotes an adrenergic beta-antagonist c59h89n19o13s.c2h4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 325o8467xk, chemically known as l-arginine, d-arginyl-l-arginyl-l-prolyl-trans-4-hydroxy-l-prolylglycyl-3-(2-thienyl)-l-alanyl-l-seryl-d-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-l-(2.alpha.,3a.beta.,7a.beta.)-octahydro-1h-indole-2-carbonyl-, acetate (salt), but more generally known as icatibant acetate, which bears us nih compound identifier 6918172. european medicines agency schedules icatibant acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub29718. most nations, for tariff and trade purposes, schedule icatibant acetate under hs 29349990 and sitc 51579. as of q4 2014, icatibant acetate remains us fdas preferred term for this commodity. icatibant acetate bears us nlm identifiers umls id c0082926 and nci concept code c98884. smiles: cc(=o)o.c1ccc2c(c1)c[c@@h](n(c2)c(=o)[c@h](co)nc(=o)[c@h](cc3cccs3)nc(=o)cnc(=o)[c@@h]4c[c@h](cn4c(=o)[c@@h]5cccn5c(=o)[c@h](cccnc(=n)n)nc(=o)[c@@h](cccnc(=n)n)n)o)c(=o)n6[c@h]7cccc[c@h]7c[c@h]6c(=o)n[c@@h](cccnc(=n)n)c(=o)o.. "
"adrenergic blocking agent amino alcohols and aminoquinolines and benzopyrans and bradykinin/analogs and derivatives. this classification denotes adrenergic blocking agent drugs made from or based in part on amino alcohols, aminoquinolines, benzopyrans, or bradykinin/analogs & derivatives. nebivolol hydrochloride. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jgs34j7l9i. european medicines agency schedules nebivolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14632mig. nebivolol hydrochloride generally arises in the molecular formula c22h25f2no4.clh. the term nebivolol hydrochloride is a united states adopted name designation. most nations, for tariff and trade purposes, schedule nebivolol hydrochloride under hs 29329985 and sitc 51569. as of q4 2014, nebivolol hydrochloride remains us fdas preferred term for this commodity. nebivolol hydrochloride bears us nlm identifiers umls id c0772208 and nci concept code c81656. smiles: c1cc2c(cc1f)cc[c@@h](o2)[c@@h](cnc[c@h]([c@@h]3ccc4cc(ccc4o3)f)o)o.cl.. "
"adrenergic blocking agent benzofurans. this classification denotes adrenergic blocking agents made from compounds that contain a benzene ring fused to a furan ring.. . "
"adrenergic blocking agent benzofurans. this classification denotes adrenergic blocking agents made from compounds that contain a benzene ring fused to a furan ring.. afurolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wq1wrv49r9. european medicines agency schedules afurolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05283mig. afurolol generally arises in the molecular formula c15h21no4. the term afurolol is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19.) afurolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, afurolol remains the us fda preferred term for this commodity. afurolol bears us nlm identifiers umls id c2348000 and nci concept code c72970. smiles: o(cc(o)cnc(c)(c)c)c1c2c(coc2=o)ccc1.. "
"adrenergic blocking agent benzofurans. this classification denotes adrenergic blocking agents made from compounds that contain a benzene ring fused to a furan ring.. efaroxan. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c13h16n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g00490l21h, chemically known as (+-)-2-(2-ethyl-2,3-dihydro-2-benzofuranyl)-2-imidazoline but generally known as efaroxan, which bears us nih compound identifier 72016. european medicines agency schedules efaroxan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06462mig. the term efaroxan is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). efaroxan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule efaroxan under hs 29349990 and sitc 51579. as of q4 2014, efaroxan remains the us fda preferred term for this commodity. efaroxan bears us nlm identifiers umls id c0058957 and nci concept code c72923. smiles: o1c(cc2c1cccc2)(cc)c1=nccn1.. "
"adrenergic blocking agent butyrophenones and carbazoles and dibenzazepines and dimethylamines. this classification denotes adrenergic blocking agent drugs made from or based in part on butyrophenones, carbazoles, dibenzazepines, or dimethylamines. . "
"adrenergic blocking agent butyrophenones and carbazoles and dibenzazepines and dimethylamines. this classification denotes adrenergic blocking agent drugs made from or based in part on butyrophenones, carbazoles, dibenzazepines, or dimethylamines. aceperone. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c24h29fn2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s69kxz59ab, chemically known as acetamide, n-((1-(4-(4-fluorophenyl)-4-oxobutyl)-4-phenyl-4-piperidinyl)methyl)- (9ci) but generally known as aceperone, which bears us nih compound identifier 13122. european medicines agency schedules aceperone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05212mig. the term aceperone is an international non-proprietary name. aceperone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule aceperone under hs 29333999 and sitc 51574. as of q4 2014, aceperone remains the us fda preferred term for this commodity. aceperone bears us nlm identifiers umls id c0649938 and nci concept code c72567. smiles: fc1ccc(c(=o)cccn2ccc(cc2)(cnc(=o)c)c2ccccc2)cc1.. "
"adrenergic blocking agent butyrophenones and carbazoles and dibenzazepines and dimethylamines. this classification denotes adrenergic blocking agent drugs made from or based in part on butyrophenones, carbazoles, dibenzazepines, or dimethylamines. carvedilol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c24h26n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0k47ul67f2, chemically known as 2-propanol, 1-(9h-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, (+-)- but generally known as carvedilol, which bears us nih compound identifier 2585. carvedilol most often comes in base and phosphate forms. european medicines agency schedules carvedilol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06153mig. the term carvedilol is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). world health organization schedules carvedilol in its anatomical therapeutic chemical (atc) classification. carvedilol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carvedilol under hs 29339990 and sitc 51577. as of q4 2014, carvedilol remains the us fda preferred term for this commodity. carvedilol bears us nlm identifiers umls id c0719509 and nci concept code c28906. smiles: o(c1c2c3c([nh]c2ccc1)cccc3)cc(o)cnccoc1c(oc)cccc1.. "
"adrenergic blocking agent butyrophenones and carbazoles and dibenzazepines and dimethylamines. this classification denotes adrenergic blocking agent drugs made from or based in part on butyrophenones, carbazoles, dibenzazepines, or dimethylamines. azapetine. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c17h17n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9ttr0ua2kc, chemically known as 6-allyl-6,7-dihydro-5h-dibenz(c,e)azepine but generally known as azapetine, which bears us nih compound identifier 8966. azapetine most often comes in base, hydrochloride, and phosphate forms. european medicines agency schedules azapetine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12970mig. world health organization schedules azapetine in its anatomical therapeutic chemical (atc) classification. as of q4 2014, azapetine remains the us fda preferred term for this commodity. azapetine bears us nlm identifiers umls id c0052752 and nci concept code c83540. smiles: n1(cc2c(c3c(c1)cccc3)cccc2)cc=c.. "
"adrenergic blocking agent butyrophenones and carbazoles and dibenzazepines and dimethylamines. this classification denotes adrenergic blocking agent drugs made from or based in part on butyrophenones, carbazoles, dibenzazepines, or dimethylamines. moxisylyte. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c16h25no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pw8qya7ki0, chemically known as phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester) but generally known as moxisylyte, which bears us nih compound identifier 4260. european medicines agency schedules moxisylyte in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09090mig. the term moxisylyte is an international non-proprietary name. world health organization schedules moxisylyte in its anatomical therapeutic chemical (atc) classification. moxisylyte is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule moxisylyte under hs 29221980 and sitc 51461. as of q4 2014, moxisylyte remains the us fda preferred term for this commodity. moxisylyte bears us nlm identifiers umls id c0040108 and nci concept code c87584. smiles: o(c1c(c(c)c)cc(oc(=o)c)c(c1)c)ccn(c)c.. "
"adrenergic blocking agent butyrophenones and carbazoles and dibenzazepines and dimethylamines. this classification denotes adrenergic blocking agent drugs made from or based in part on butyrophenones, carbazoles, dibenzazepines, or dimethylamines. carvedilol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c24h26n2o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n9a00dj8cm. most nations, for tariff and trade purposes, schedule carvedilol hydrochloride under hs 29339990 and sitc 51577. as of q4 2014, carvedilol hydrochloride remains us fdas preferred term for this commodity. smiles: coc1ccccc1occncc(coc2cccc3c2c4ccccc4[nh]3)o.cl.. "
"adrenergic blocking agent butyrophenones and carbazoles and dibenzazepines and dimethylamines. this classification denotes adrenergic blocking agent drugs made from or based in part on butyrophenones, carbazoles, dibenzazepines, or dimethylamines. carvedilol phosphate. this classification denotes a beta-adrenergic blocking agent with the molecular formula 2c24h26n2o4.h2o.2h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier eqt531s367, chemically known as 2-propanol, 1-(9h-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino) , phosphate (salt), hydrate (2:2:1), but more generally known as carvedilol phosphate, which bears us nih compound identifier 11954344. european medicines agency schedules carvedilol phosphate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06153mig. most nations, for tariff purposes, schedule carvedilol phosphate under hs 29339990. carvedilol phosphate bears us nlm identifiers umls id c1815010 and nci concept code c65292. smiles: coc1ccccc1occncc(coc2cccc3c2c4ccccc4[nh]3)o.coc1ccccc1occncc(coc2cccc3c2c4ccccc4[nh]3)o.o.op(=o)(o)o.op(=o)(o)o.. "
"adrenergic blocking agent butyrophenones and carbazoles and dibenzazepines and dimethylamines. this classification denotes adrenergic blocking agent drugs made from or based in part on butyrophenones, carbazoles, dibenzazepines, or dimethylamines. moxisylyte hydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c16h25no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wk2kzm9v6x, chemically known as phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester) but more generally known as moxisylyte hydrochloride, which bears us nih compound identifier 4260. european medicines agency schedules moxisylyte hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03343mig. most nations, for tariff and trade purposes, schedule moxisylyte hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, moxisylyte hydrochloride remains us fdas preferred term for this commodity. moxisylyte hydrochloride bears us nlm identifiers umls id c1563915 and nci concept code c87585. smiles: cc1cc(c(cc1oc(=o)c)c(c)c)occn(c)c.cl.. "
"adrenergic blocking agent indoles. this classification denotes adrenergic blocking agents made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. . "
"adrenergic blocking agent indoles. this classification denotes adrenergic blocking agents made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. atiprosin. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c20h29n3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, als52889wf chemically known as pyrazino(2,3:3,4)pyrido(1,2-a)indole, 1-ethyl-1,2,3,4,4a,5,6,12b-octahydro-12-methyl-4-(1-methylethyl)-, trans, (z)-2-butenedioate but generally known as atiprosin, which bears us nih compound identifier 3034029. european medicines agency schedules atiprosin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05596mig. the term atiprosin is an international non-proprietary name or inn. most nations schedule atiprosin under hs 29335995 and sitc 51576. as of q4 2014, atiprosin remains the us fda preferred term for this commodity. atiprosin bears us nlm identifiers umls id c0052594 and nci concept code c77299. smiles: ccn1ccn(c2c1c3=c(c4=cc=cc=c4n3cc2)c)c(c)c.. "
"adrenergic blocking agent indoles. this classification denotes adrenergic blocking agents made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. silodosin. this classification denotes an alpha-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cuz39luy82. european medicines agency schedules silodosin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub23152. silodosin generally arises in the molecular formula c25h32f3n3o4. the term silodosin is an international non-proprietary name or inn (see who inn reference publication, volume 16., no. 1.2002, list 47.) most nations schedule silodosin under hs 29339990 and sitc 51577. as of q4 2014, silodosin remains the us fda preferred term for this commodity. silodosin bears us nlm identifiers umls id c1870115 and nci concept code c81372. smiles: fc(f)(f)coc1c(occnc(cc2cc3c(n(cc3)ccco)c(c2)c(=o)n)c)cccc1.. "
"adrenergic blocking agent indoles. this classification denotes adrenergic blocking agents made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. tinazoline. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c11h11n3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 88174ak70t, chemically known as 1h-indole, 3-((4,5-dihydro-1h-imidazol-2-yl)thio)-, monohydrochloride but generally known as tinazoline, which bears us nih compound identifier 68818. european medicines agency schedules tinazoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11073mig. the term tinazoline is an international non-proprietary name. tinazoline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tinazoline under hs 29332990 and sitc 51573. as of q4 2014, tinazoline remains the us fda preferred term for this commodity. tinazoline bears us nlm identifiers umls id c0076698 and nci concept code c75057. smiles: c1cn=c(n1)sc2=cnc3=cc=cc=c32.. "
"adrenergic blocking agent indoles. this classification denotes adrenergic blocking agents made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. atiprosin maleate. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c20h29n3.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 50sz4782j0, chemically known as pyrazino(2,3:3,4)pyrido(1,2-a)indole, 1-ethyl-1,2,3,4,4a,5,6,12b-octahydro-12-methyl-4-(1-methylethyl)-, trans- but more generally known as atiprosin maleate, which bears us nih compound identifier 3034029. most nations, for tariff and trade purposes, schedule atiprosin maleate under hs 29335995 and sitc 51576. as of q4 2014, atiprosin maleate remains us fdas preferred term for this commodity. atiprosin maleate bears us nlm identifiers umls id c0104775 and nci concept code c87434. smiles: ccn1ccn([c@h]2[c@h]1c3c(c4ccccc4n3cc2)c)c(c)c.c(=c\\c(=o)o)\\c(=o)o.. "
"adrenergic blocking agent dioxanes. this classification denotes adrenergic blocking agents made from 1,4-diethylene dioxides.. . "
"adrenergic blocking agent dioxanes. this classification denotes adrenergic blocking agents made from 1,4-diethylene dioxides.. piperoxan. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c14h19no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9zcs27634y, chemically known as 1,4-benzodioxane, 2-(piperidinomethyl)- but generally known as piperoxan, which bears us nih compound identifier 6040. european medicines agency schedules piperoxan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09872mig. the term piperoxan is an international non-proprietary name. piperoxan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule piperoxan under hs 29349990 and sitc 51579. as of q4 2014, piperoxan remains the us fda preferred term for this commodity. piperoxan bears us nlm identifiers umls id c0031963 and nci concept code c66399. smiles: o1c(cn2ccccc2)coc2c1cccc2.. "
"adrenergic blocking agent dioxanes. this classification denotes adrenergic blocking agents made from 1,4-diethylene dioxides.. proroxan. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c21h23no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, t5wt3qn49g chemically known as 1-(1,4-benzodioxan-6-yl)-3-(3-phenyl-1-pyrrolidinyl)-1-propanone but generally known as proroxan, which bears us nih compound identifier 36303. european medicines agency schedules proroxan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10130mig. the term proroxan is an international non-proprietary name or inn. most nations schedule proroxan under hs 29349990 and sitc 51579. as of q4 2014, proroxan remains the us fda preferred term for this commodity. proroxan bears us nlm identifiers umls id c0072252 and nci concept code c84119. smiles: c1cn(cc1c2=cc=cc=c2)ccc(=o)c3=cc4=c(c=c3)occo4.. "
"adrenergic blocking agent dioxanes. this classification denotes adrenergic blocking agents made from 1,4-diethylene dioxides.. spiroxatrine. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c22h25n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dr0qr50all, chemically known as 1,3,8-trianaspiro(4.5)decane-4-one,8-(1,4-benzodioxan-2-ylmethyl)-1-phenyl- but generally known as spiroxatrine, which bears us nih compound identifier 5268. european medicines agency schedules spiroxatrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10635mig. the term spiroxatrine is an international non-proprietary name. spiroxatrine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule spiroxatrine under hs 29349990 and sitc 51579. as of q4 2014, spiroxatrine remains the us fda preferred term for this commodity. spiroxatrine bears us nlm identifiers umls id c0075025 and nci concept code c74108. smiles: o=c1ncn(c21ccn(cc2)cc1oc2c(oc1)cccc2)c1ccccc1.. "
"adrenergic blocking agent dioxanes. this classification denotes adrenergic blocking agents made from 1,4-diethylene dioxides.. piperoxan hydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c14h19no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ks0dz1uqnw, chemically known as 1,4-benzodioxan, 2-(1-piperidylmethyl)-, hydrochloride but more generally known as piperoxan hydrochloride, which bears us nih compound identifier 101619. most nations, for tariff and trade purposes, schedule piperoxan hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, piperoxan hydrochloride remains us fdas preferred term for this commodity. piperoxan hydrochloride bears us nlm identifiers umls id c2825596 and nci concept code c81370. smiles: c1ccc2c(c1)occ(o2)cn3ccccc3.cl.. "
"adrenergic blocking agent dioxanes. this classification denotes adrenergic blocking agents made from 1,4-diethylene dioxides.. proroxan hydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c21h23no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 694z9p44g4, chemically known as 1,4-benzodioxan, 6-(3-(3-phenylpyrrolidinyl)propionyl)-, hydrochloride but more generally known as proroxan hydrochloride, which bears us nih compound identifier 36302. most nations, for tariff and trade purposes, schedule proroxan hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, proroxan hydrochloride remains us fdas preferred term for this commodity. proroxan hydrochloride bears us nlm identifiers umls id c0951999 and nci concept code c84120. smiles: c1ccc(cc1)c2ccn(c2)ccc(=o)c3ccc4c(c3)occo4.cl.. "
"adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines. this classification denotes adrenergic blocking agent drugs made from or based in part on ergolines, heterocyclic compounds, 3-ring, morpholines, or pyridazines. . "
"adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines. this classification denotes adrenergic blocking agent drugs made from or based in part on ergolines, heterocyclic compounds, 3-ring, morpholines, or pyridazines. epicriptine. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c32h43n5o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5m64643b5u, chemically known as 9,10alpha-dihydro-13-epi-beta-ergocryptine but generally known as epicriptine, which bears us nih compound identifier 65667. european medicines agency schedules epicriptine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06564mig. the term epicriptine is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). epicriptine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule epicriptine under hs 29396900 and sitc 54146. as of q4 2014, epicriptine remains the us fda preferred term for this commodity. epicriptine bears us nlm identifiers umls id c0304433 and nci concept code c75934. smiles: o1c2(o)n(c(c(=o)n3c2ccc3)c(cc)c)c(=o)c1(nc(=o)c1cc2c(n(c1)c)cc1c3c2cccc3[nh]c1)c(c)c.. "
"adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines. this classification denotes adrenergic blocking agent drugs made from or based in part on ergolines, heterocyclic compounds, 3-ring, morpholines, or pyridazines. fiduxosin. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c30h29n5o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w9o92hyt6i, chemically known as 8-phenyl-3-(4-((3ar,9br)-1,3a,4,9b-tetrahydro-9-methoxy(1)benzopyrano(3,4-c)pyrrol-2(3h)-yl)butyl)pyrazino(2,3:4,5)thieno(3,2-d)pyrimidine-2,4(1h,3h)-dione. but generally known as fiduxosin, which bears us nih compound identifier 172307. the term fiduxosin is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 3, 2000, list 44). most nations schedule fiduxosin under hs 29349990 and sitc 51579. as of q4 2014, fiduxosin remains the us fda preferred term for this commodity. fiduxosin bears us nlm identifiers umls id c1120505 and nci concept code c65682. smiles: coc1=cc=cc2=c1c3cn(cc3co2)ccccn4c(=o)c5=c(c6=nc(=cn=c6s5)c7=cc=cc=c7)nc4=o.. "
"adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines. this classification denotes adrenergic blocking agent drugs made from or based in part on ergolines, heterocyclic compounds, 3-ring, morpholines, or pyridazines. viloxazine. this classification denotes an adrenergic uptake inhibitor and second-generation antidepressive agent with the molecular formula c13h19no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5i5y2789zf, chemically known as 2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine but generally known as viloxazine, which bears us nih compound identifier 5666. european medicines agency schedules viloxazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00049mig. world health organization schedules viloxazine in its anatomical therapeutic chemical (atc) classification. viloxazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule viloxazine under hs 29349990 and sitc 51579. as of q4 2014, viloxazine remains the us fda preferred term for this commodity. smiles: o1c(cncc1)coc1c(occ)cccc1.. "
"adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines. this classification denotes adrenergic blocking agent drugs made from or based in part on ergolines, heterocyclic compounds, 3-ring, morpholines, or pyridazines. pirepolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c21h32n4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v1j0b4p41o, chemically known as (+-)-6-((2-((3-(p-butoxyphenoxy)-2-hydroxypropyl)amino)ethyl)amino)-1,3-dimethyluracil but generally known as pirepolol, which bears us nih compound identifier 68887. european medicines agency schedules pirepolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09905mig. the term pirepolol is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). pirepolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pirepolol under hs 29335995 and sitc 51576. as of q4 2014, pirepolol remains the us fda preferred term for this commodity. pirepolol bears us nlm identifiers umls id c1882394 and nci concept code c66418. smiles: o(cc(o)cnccnc1n(c(=o)n(c(=o)c1)c)c)c1ccc(occcc)cc1.. "
"adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines. this classification denotes adrenergic blocking agent drugs made from or based in part on ergolines, heterocyclic compounds, 3-ring, morpholines, or pyridazines. ridazolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2r4qo1868y. european medicines agency schedules ridazolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10302mig. ridazolol generally arises in the molecular formula c15h18cl2n4o3. the term ridazolol is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24.) ridazolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ridazolol under hs 29339990 and sitc 51577. as of q4 2014, ridazolol remains the us fda preferred term for this commodity. ridazolol bears us nlm identifiers umls id c0073362 and nci concept code c76559. smiles: clc1c(nccncc(o)coc2c(cl)cccc2)cn[nh]c1=o.. "
"adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines. this classification denotes adrenergic blocking agent drugs made from or based in part on ergolines, heterocyclic compounds, 3-ring, morpholines, or pyridazines. fiduxosin hydrochloride. this classification denotes an alpha-adrenergic blocking agent c30h29n5o4s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uyv23l1n89, chemically known as pyrazino(2,3:4,5)thieno(3,2-d)pyrimidine-2,4(1h,3h)-dione, 8-phenyl-3-(4-((3ar,9br)-1,3a,4,9b-tetrahydro-9-methoxy(1)benzopyrano(3,4-c)pyrrol-2(3h)-yl)butyl)-, monohydrochloride, but more generally known as fiduxosin hydrochloride, which bears us nih compound identifier 172306. most nations, for tariff and trade purposes, schedule fiduxosin hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, fiduxosin hydrochloride remains us fdas preferred term for this commodity. fiduxosin hydrochloride bears us nlm identifiers umls id c2825597 and nci concept code c81371. smiles: coc1cccc2c1[c@@h]3cn(c[c@@h]3co2)ccccn4c(=o)c5c(c6c(s5)ncc(n6)c7ccccc7)[nh]c4=o.cl.. "
"adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines. this classification denotes adrenergic blocking agent drugs made from or based in part on ergolines, heterocyclic compounds, 3-ring, morpholines, or pyridazines. viloxazine hydrochloride. this classification denotes the hydrochloride form of an adrenergic uptake inhibitor and second-generation antidepressive agent with the molecular formula c13h19no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5i5y2789zf, chemically known as 2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine but more generally known as viloxazine, which bears us nih compound identifier 5666. european medicines agency schedules viloxazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00049mig. world health organization schedules viloxazine in its anatomical therapeutic chemical (atc) classification. viloxazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule viloxazine hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, viloxazine hydrochloride remains us fdas preferred term for this commodity. smiles: ccoc1ccccc1occ2cncco2.cl.. "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. . "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. procaterol. this classification denotes an adrenergic beta-2 receptor agonist, bronchodilator agent, and sympathomimetic with the molecular formula c16h22n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x7i3emm5k0, chemically known as 8-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1h)-quinolinone (r*,s*)-(+-)- but generally known as procaterol, which bears us nih compound identifier 4916. european medicines agency schedules procaterol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10058mig. world health organization schedules procaterol in its anatomical therapeutic chemical (atc) classification. procaterol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule procaterol under hs 29337900 and sitc 51561. as of q4 2014, procaterol remains the us fda preferred term for this commodity. smiles: oc(c(nc(c)c)cc)c1c2c([nh]c(=o)cc2)c(o)cc1.. "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. pronetalol or pronethalol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c15h19no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xbp4rt1imq, chemically known as 2-naphthalenemethanol, alpha-((isopropylamino)methyl)- but generally known as pronetalol, which bears us nih compound identifier 4930. european medicines agency schedules pronetalol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10092mig. the term pronetalol is an international non-proprietary name. pronetalol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. pronetalol or pronethalol bears us nlm identifiers umls id c0033424 and nci concept code c82257. smiles: cc(c)ncc(c1=cc2=cc=cc=c2c=c1)o.. "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. amosulalol. this classification denotes an adrenergic antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c69ji1bau8. european medicines agency schedules amosulalol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05478mig. amosulalol generally arises in the molecular formula c18h24n2o5s. the term amosulalol is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24.) amosulalol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amosulalol under hs 29350090 and sitc 51580. as of q4 2014, amosulalol remains the us fda preferred term for this commodity. amosulalol bears us nlm identifiers umls id c0103116 and nci concept code c72916. smiles: s(=o)(=o)(n)c1cc(c(o)cnccoc2c(oc)cccc2)ccc1c.. "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. labetalol. this classification denotes an adrenergic antagonist with the molecular formula c19h24n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r5h8897n95, chemically known as benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)- but generally known as labetalol, which bears us nih compound identifier 3869. european medicines agency schedules labetalol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08382mig. the term labetalol is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). world health organization schedules labetalol in its anatomical therapeutic chemical (atc) classification. labetalol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule labetalol under hs 29242995 and sitc 51479. as of q4 2014, labetalol remains the us fda preferred term for this commodity. labetalol bears us nlm identifiers umls id c0022860 and nci concept code c29146. smiles: oc(cnc(ccc1ccccc1)c)c1cc(c(o)cc1)c(=o)n.. "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. reproterol. this classification denotes a metaproterenol analog, adrenergic beta-agonists, and bronchodilator agent with the molecular formula c18h23n5o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 11941yc6rn, chemically known as 1,2,3,6-tetrahydro-1,3-dimethyl-7-(3-((beta,3,5-trihydroxyphenethyl)amino)propyl)-2,6-purindion but generally known as reproterol, which bears us nih compound identifier 25654. european medicines agency schedules reproterol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10283mig. world health organization schedules reproterol in its anatomical therapeutic chemical (atc) classification. reproterol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule reproterol under hs 29395900 and sitc 54145. as of q4 2014, reproterol remains the us fda preferred term for this commodity. smiles: oc(cncccn1c2c(n(c(=o)n(c2=o)c)c)nc1)c1cc(o)cc(o)c1.. "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. terbutaline. this classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula c12h19no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n8onu3l3pg, chemically known as 1,3-benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)- (9ci) but generally known as terbutaline, which bears us nih compound identifier 5403. european medicines agency schedules terbutaline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10915mig. the term terbutaline is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules terbutaline in its anatomical therapeutic chemical (atc) classification. terbutaline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule terbutaline under hs 29225000 and sitc 51467. as of q4 2014, terbutaline remains the us fda preferred term for this commodity. terbutaline bears us nlm identifiers umls id c0039542 and nci concept code c61965. smiles: cc(c)(c)ncc(c1=cc(=cc(=c1)o)o)o.. "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. amosulalol hydrochloride. this classification denotes an adrenergic antagonist with the molecular formula c18h24n2o5s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4o4s698pee, chemically known as benzenesulfonamide, 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methyl-, monohydrochloride but more generally known as amosulalol hydrochloride, which bears us nih compound identifier 123707. the base compound, amosulalol, most often comes in base and hydrochloride forms. european medicines agency schedules amosulalol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00502mig. most nations, for tariff and trade purposes, schedule amosulalol hydrochloride under hs 29350090 and sitc 51580. as of q4 2014, amosulalol hydrochloride remains us fdas preferred term for this commodity. smiles: cc1ccc(cc1s(=o)(=o)n)c(cnccoc2ccccc2oc)o.cl.. "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. amosulalol monohydrochloride. this classification denotes an adrenergic antagonist with the molecular formula c18h24n2o5s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4o4s698pee, chemically known as benzenesulfonamide, 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methyl-, hydrochloride (1:1), but more generally known as amosulalol monohydrochloride, which bears us nih compound identifier 123707. european medicines agency schedules amosulalol monohydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05478mig. most nations, for tariff purposes, schedule amosulalol monohydrochloride under hs 29350090. smiles: cc1ccc(cc1s(=o)(=o)n)c(cnccoc2ccccc2oc)o.cl.. "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. labetalol hydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c19h24n2o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1gev3baw9j, chemically known as benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)- but more generally known as labetalol hydrochloride, which bears us nih compound identifier 3869. european medicines agency schedules labetalol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02844mig. most nations, for tariff and trade purposes, schedule labetalol hydrochloride under hs 29242995 and sitc 51479. as of q4 2014, labetalol hydrochloride remains us fdas preferred term for this commodity. labetalol hydrochloride bears us nlm identifiers umls id c0699440 and nci concept code c63578. smiles: cc(ccc1ccccc1)ncc(c2ccc(c(c2)c(=o)n)o)o.cl.. "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. procaterol hydrochloride. this classification denotes an adrenergic beta-2 receptor agonist c16h22n2o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4vd1brt7t8, chemically known as 2(1h)-quinolinone, 8-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-, monohydrochloride, (r*,s*), (+/-)-, but more generally known as procaterol hydrochloride, which bears us nih compound identifier 43091. european medicines agency schedules procaterol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04050mig. most nations, for tariff and trade purposes, schedule procaterol hydrochloride under hs 29337900 and sitc 51561. as of q4 2014, procaterol hydrochloride remains us fdas preferred term for this commodity. smiles: cc[c@h]([c@h](c1ccc(c2c1ccc(=o)[nh]2)o)o)nc(c)c.cl.. "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. procaterol hydrochloride hemihydrate. this classification denotes an adrenergic beta-2 receptor agonist, bronchodilator agent, and sympathomimetic with the molecular formula 2c16h22n2o3.2clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8404i5hkfj, chemically known as 2(1h)-quinolinone, 8-hydroxy-5-((1r,2s)-1-hydroxy-2-((1-methylethyl)amino)butyl)-, hydrochloride, hydrate (2:2:1), rel-, but more generally known as procaterol hydrochloride hemihydrate, which bears us nih compound identifier 6917801. european medicines agency schedules procaterol hydrochloride hemihydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10058mig. most nations, for tariff purposes, schedule procaterol hydrochloride hemihydrate under hs 29337900. smiles: cc[c@h]([c@h](c1ccc(c2c1ccc(=o)[nh]2)o)o)nc(c)c.cc[c@h]([c@h](c1ccc(c2c1ccc(=o)[nh]2)o)o)nc(c)c.o.cl.cl.. "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. reproterol hydrochloride. this classification denotes a metaproterenol analog c18h23n5o5.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y4i1coj8w8, chemically known as 1h-purine-2,6-dione, 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-3,7-dihydro-1,3-dimethyl-, monohydrochloride, but more generally known as reproterol hydrochloride, which bears us nih compound identifier 3032600. european medicines agency schedules reproterol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04218mig. most nations, for tariff and trade purposes, schedule reproterol hydrochloride under hs 29395900 and sitc 54145. as of q4 2014, reproterol hydrochloride remains us fdas preferred term for this commodity. smiles: cn1c2c(c(=o)n(c1=o)c)n(cn2)cccncc(c3cc(cc(c3)o)o)o.cl.. "
"adrenergic blocking agent ethanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the ethanolamine (-nh2ch2choh) group and its derivatives.. terbutaline sulfate. this classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula 2c12h19no3.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 576pu70y8e, chemically known as 1,3-benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)- (9ci) but more generally known as terbutaline sulfate, which bears us nih compound identifier 5403. european medicines agency schedules terbutaline sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04724mig. most nations, for tariff and trade purposes, schedule terbutaline sulfate under hs 29225000 and sitc 51467. as of q4 2014, terbutaline sulfate remains us fdas preferred term for this commodity. terbutaline sulfate bears us nlm identifiers umls id c0591192 and nci concept code c47748. smiles: cc(c)(c)ncc(c1cc(cc(c1)o)o)o.cc(c)(c)ncc(c1cc(cc(c1)o)o)o.os(=o)(=o)o.. "
"adrenergic blocking agent guanidines. this classification denotes adrenergic blocking agents made from a family of iminourea derivatives.. . "
"adrenergic blocking agent guanidines. this classification denotes adrenergic blocking agents made from a family of iminourea derivatives.. betanidine or bethanidine. this classification denotes an adrenergic antagonist with the molecular formula c10h15n3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w8s3ym7auu, chemically known as 2-benzyl-1,3-dimethylguanidine but generally known as betanidine, which bears us nih compound identifier 2368. betanidine most often comes in base and sulfate forms. european medicines agency schedules betanidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05801mig. the term betanidine is an international non-proprietary name. world health organization schedules betanidine in its anatomical therapeutic chemical (atc) classification. betanidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. betanidine or bethanidine bears us nlm identifiers umls id c0005324 and nci concept code c81343. smiles: cnc(=nc)ncc1=cc=cc=c1.. "
"adrenergic blocking agent guanidines. this classification denotes adrenergic blocking agents made from a family of iminourea derivatives.. guanazodine. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c9h20n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7n05kq38yi, chemically known as guanidine, ((octahydro-2-azocinyl)methyl)- (8ci,9ci) but generally known as guanazodine, which bears us nih compound identifier 36054. european medicines agency schedules guanazodine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07981mig. the term guanazodine is an international non-proprietary name. world health organization schedules guanazodine in its anatomical therapeutic chemical (atc) classification. guanazodine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule guanazodine under hs 29339990 and sitc 51577. as of q4 2014, guanazodine remains the us fda preferred term for this commodity. guanazodine bears us nlm identifiers umls id c0061940 and nci concept code c83741. smiles: n1c(cccccc1)c/n=c(/n)n.. "
"adrenergic blocking agent guanidines. this classification denotes adrenergic blocking agents made from a family of iminourea derivatives.. guanoxan. this classification denotes a guanidine and antihypertensive agent with the molecular formula c10h13n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9v0mrl0r5y, chemically known as guanidine, ((2,3-dihydro-1,4-benzodioxin-2-yl)methyl)- (9ci) but generally known as guanoxan, which bears us nih compound identifier 16564. european medicines agency schedules guanoxan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07989mig. world health organization schedules guanoxan in its anatomical therapeutic chemical (atc) classification. guanoxan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule guanoxan under hs 29329985 and sitc 51569. as of q4 2014, guanoxan remains the us fda preferred term for this commodity. smiles: c1c(oc2=cc=cc=c2o1)cn=c(n)n.. "
"adrenergic blocking agent guanidines. this classification denotes adrenergic blocking agents made from a family of iminourea derivatives.. betanidine sulfate. this classification denotes an antihypertensive agent and adrenergic antagonist with the molecular formula 2c10h15n3.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j4thi5n7o2, chemically known as 2-benzyl-1,3-dimethylguanidine but more generally known as betanidine sulfate, which bears us nih compound identifier 2368. european medicines agency schedules betanidine sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00787mig. most nations, for tariff and trade purposes, schedule betanidine sulfate under hs 29252900. smiles: cnc(=ncc1ccccc1)nc.cnc(=ncc1ccccc1)nc.os(=o)(=o)o.. "
"adrenergic blocking agent guanidines. this classification denotes adrenergic blocking agents made from a family of iminourea derivatives.. guanazodine sulfate. this classification denotes an alpha-adrenergic agonist with the molecular formula c9h20n4.h2o.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uki3dao4s6. the term guanazodine sulfate is a u.s. fda designation. most nations, for tariff and trade purposes, schedule guanazodine sulfate under hs 29339990 and sitc 51577. smiles: c1cccnc(cc1)cnc(=n)n.os(=o)(=o)o.. "
"adrenergic blocking agent guanidines. this classification denotes adrenergic blocking agents made from a family of iminourea derivatives.. guanazodine sulfate monohydrate. this classification denotes an alpha-adrenergic agonist with the molecular formula c9h20n4.h2o.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uki3dao4s6. the term guanazodine sulfate is a u.s. fda designation. most nations, for tariff and trade purposes, schedule guanazodine sulfate monohydrate under hs 29339990. as of q4 2014, guanazodine sulfate monohydrate remains us fdas preferred term for this commodity. guanazodine sulfate monohydrate bears us nlm identifiers umls id c2827164 and nci concept code c83742. smiles: c1cccnc(cc1)cnc(=n)n.o.os(=o)(=o)o.. "
"adrenergic blocking agent guanidines. this classification denotes adrenergic blocking agents made from a family of iminourea derivatives.. guanoxan sulfate. this classification denotes a guanidine and antihypertensive agent 2c10h13n3o2.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n6it80r85g, chemically known as (1,4-benzodioxan-2-yl-methyl)guanidine sulfate (2:1), but more generally known as guanoxan sulfate, which bears us nih compound identifier 21942. european medicines agency schedules guanoxan sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02432mig. most nations, for tariff and trade purposes, schedule guanoxan sulfate under hs 29329985 and sitc 51569. as of q4 2014, guanoxan sulfate remains us fdas preferred term for this commodity. smiles: c1ccc2c(c1)occ(o2)cnc(=n)n.c1ccc2c(c1)occ(o2)cnc(=n)n.os(=o)(=o)o.. "
"adrenergic blocking agent imidazoles. this classification denotes adrenergic blocking agents made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. . "
"adrenergic blocking agent imidazoles. this classification denotes adrenergic blocking agents made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. atipamezole. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c14h16n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 03n9u5jaf6, chemically known as 1h-imidazole, 4-(2-ethyl-2,3-dihydro-1h-inden-2-yl)- but generally known as atipamezole, which bears us nih compound identifier 71310. european medicines agency schedules atipamezole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05594mig. the term atipamezole is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). most nations schedule atipamezole under hs 29332990 and sitc 51573. as of q4 2014, atipamezole remains the us fda preferred term for this commodity. atipamezole bears us nlm identifiers umls id c0052593 and nci concept code c72921. smiles: [nh]1c(c2(cc3c(c2)cccc3)cc)cnc1.. "
"adrenergic blocking agent imidazoles. this classification denotes adrenergic blocking agents made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. imiloxan. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c14h16n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zj56ps1dwk, chemically known as 1h-imidazole, 2-((2,3-dihydro-1,4-benzodioxin-2-yl)methyl)-1-ethyl-, (7r-(7alpha,8beta,10beta))- but generally known as imiloxan, which bears us nih compound identifier 133621. european medicines agency schedules imiloxan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08149mig. the term imiloxan is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). imiloxan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule imiloxan under hs 29349990 and sitc 51579. as of q4 2014, imiloxan remains the us fda preferred term for this commodity. imiloxan bears us nlm identifiers umls id c0063395 and nci concept code c83792. smiles: o1c(cc2n(cc)ccn2)coc2c1cccc2.. "
"adrenergic blocking agent imidazoles. this classification denotes adrenergic blocking agents made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. napamezole. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c14h16n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gk4c2d295b, chemically known as 2-((3,4-dihydro-2-naphthyl)methyl)-2-imidazoline but generally known as napamezole, which bears us nih compound identifier 124655. european medicines agency schedules napamezole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09153mig. the term napamezole is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). napamezole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule napamezole under hs 29332990 and sitc 51573. as of q4 2014, napamezole remains the us fda preferred term for this commodity. napamezole bears us nlm identifiers umls id c0083703 and nci concept code c83985. smiles: n1cc(=nc1)cc1=cc2c(cc1)cccc2.. "
"adrenergic blocking agent imidazoles. this classification denotes adrenergic blocking agents made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. phentolamine. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c17h19n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z468598hbv, chemically known as 2-imidazoline, 2-((n-(m-hydroxyphenyl)-p-toluidino)methyl)- but generally known as phentolamine, which bears us nih compound identifier 5775. european medicines agency schedules phentolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09785mig. the term phentolamine is an international non-proprietary name. world health organization schedules phentolamine in its anatomical therapeutic chemical (atc) classification. phentolamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule phentolamine under hs 29332910 and sitc 51573. as of q4 2014, phentolamine remains the us fda preferred term for this commodity. phentolamine bears us nlm identifiers umls id c0031448 and nci concept code c62066. smiles: oc1cc(n(cc2=nccn2)c2ccc(cc2)c)ccc1.. "
"adrenergic blocking agent imidazoles. this classification denotes adrenergic blocking agents made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. atipamezole hydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c14h16n2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2w4279571x. the term atipamezole hydrochloride is a u.s. fda green book designation. most nations, for tariff and trade purposes, schedule atipamezole hydrochloride under hs 29332990 and sitc 51573. as of q4 2014, atipamezole hydrochloride remains us fdas preferred term for this commodity. atipamezole hydrochloride bears us nlm identifiers umls id c1289965 and nci concept code c80011. smiles: ccc1(cc2ccccc2c1)c3cnc[nh]3.cl.. "
"adrenergic blocking agent imidazoles. this classification denotes adrenergic blocking agents made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. imiloxan hydrochloride. this classification denotes an alpha-adrenergic blocking agent c14h16n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x72fo6zlzy, chemically known as (+/-)-2-(1,4-benzodioxan-2-ylmethyl)-1-ethylimidazole monohydrochloride, but more generally known as imiloxan hydrochloride, which bears us nih compound identifier 172975. most nations, for tariff and trade purposes, schedule imiloxan hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, imiloxan hydrochloride remains us fdas preferred term for this commodity. imiloxan hydrochloride bears us nlm identifiers umls id c2827196 and nci concept code c83793. smiles: ccn1ccnc1cc2coc3ccccc3o2.cl.. "
"adrenergic blocking agent imidazoles. this classification denotes adrenergic blocking agents made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. napamezole hydrochloride. this classification denotes a serotonin agonist and alpha-adrenergic blocking agent with the molecular formula c14h16n2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dtn86h1zwk, chemically known as 2-((3,4-dihydro-2-naphthyl)methyl)-2-imidazoline hydrochloride but more generally known as napamezole hydrochloride, which bears us nih compound identifier 3033727. most nations, for tariff and trade purposes, schedule napamezole hydrochloride under hs 29332990 and sitc 51573. as of q4 2014, napamezole hydrochloride remains us fdas preferred term for this commodity. napamezole hydrochloride bears us nlm identifiers umls id c2825583 and nci concept code c81333. smiles: c1ccc2c(c1)ccc(=c2)cc3=nccn3.cl.. "
"adrenergic blocking agent imidazoles. this classification denotes adrenergic blocking agents made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. phentolamine hydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c17h19n3o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 86drw83r1h, chemically known as 3-(((4,5-dihydro-1h-imidazol-2-yl)methyl)(4-methylphenyl)amino)phenol hydrochloride but more generally known as phentolamine hydrochloride, which bears us nih compound identifier 66147. european medicines agency schedules phentolamine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22729. most nations, for tariff and trade purposes, schedule phentolamine hydrochloride under hs 29332910 and sitc 51573. as of q4 2014, phentolamine hydrochloride remains us fdas preferred term for this commodity. phentolamine hydrochloride bears us nlm identifiers umls id c2698793 and nci concept code c80007. smiles: cc1ccc(cc1)n(cc2=nccn2)c3cccc(c3)o.cl.. "
"adrenergic blocking agent imidazoles. this classification denotes adrenergic blocking agents made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. phentolamine mesilate or mesylate. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c17h19n3o.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y7543e5k9t, chemically known as m-(n-(2-imidazolin-2-ylmethyl)-p-toluidino)phenol monomethanesulfonate (salt), but more generally known as phentolamine mesylate, which bears us nih compound identifier 5775. european medicines agency schedules phentolamine mesylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09785mig. most nations, for tariff purposes, schedule phentolamine mesylate under hs 29332910. as of q4 2014, phentolamine mesylate remains us fdas preferred term for this commodity. phentolamine mesylate bears us nlm identifiers umls id c0733398 and nci concept code c38691. smiles: cc1ccc(cc1)n(cc2=nccn2)c3cccc(c3)o.cs(=o)(=o)o.. "
"adrenergic blocking agent imidazolines. this classification denotes adrenergic blocking agents made from compounds based on reduced imidazoles containing a single double bond.. . "
"adrenergic blocking agent imidazolines. this classification denotes adrenergic blocking agents made from compounds based on reduced imidazoles containing a single double bond.. tolazoline. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c10h12n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier chh9h12aq3, chemically known as 4,5-dihydro-2-(phenylmethyl)-1h-imidazole but generally known as tolazoline, which bears us nih compound identifier 5504. european medicines agency schedules tolazoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11148mig. the term tolazoline is an international non-proprietary name. world health organization schedules tolazoline in its anatomical therapeutic chemical (atc) classification. tolazoline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tolazoline under hs 29332990 and sitc 51573. as of q4 2014, tolazoline remains the us fda preferred term for this commodity. tolazoline bears us nlm identifiers umls id c0040373 and nci concept code c66608. smiles: c1cn=c(n1)cc2=cc=cc=c2.. "
"adrenergic blocking agent imidazolines. this classification denotes adrenergic blocking agents made from compounds based on reduced imidazoles containing a single double bond.. tymazoline. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c14h20n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u993rh5585, chemically known as 1,4,5-dihydro-2-(2-isopropyl-5-methylphenoxymethyl)imidazol but generally known as tymazoline, which bears us nih compound identifier 34154. european medicines agency schedules tymazoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15640mig. world health organization schedules tymazoline in its anatomical therapeutic chemical (atc) classification. as of q4 2014, tymazoline remains the us fda preferred term for this commodity. tymazoline bears us nlm identifiers umls id c0771442 and nci concept code c95309. smiles: o(c1c(c(c)c)ccc(c1)c)cc1=nccn1.. "
"adrenergic blocking agent imidazolines. this classification denotes adrenergic blocking agents made from compounds based on reduced imidazoles containing a single double bond.. tolazoline hydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c10h12n2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e669z6s1jg, chemically known as 4,5-dihydro-2-(phenylmethyl)-1h-imidazole monohydrochloride but more generally known as tolazoline hydrochloride, which bears us nih compound identifier 6048. european medicines agency schedules tolazoline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04906mig. most nations, for tariff and trade purposes, schedule tolazoline hydrochloride under hs 29332990 and sitc 51573. as of q4 2014, tolazoline hydrochloride remains us fdas preferred term for this commodity. tolazoline hydrochloride bears us nlm identifiers umls id c0770500 and nci concept code c66609. smiles: c1ccc(cc1)cc2=nccn2.cl.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. . "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. pindolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c14h20n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bj4hf6iu1d, chemically known as 2-propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, (+-)- but generally known as pindolol, which bears us nih compound identifier 4828. european medicines agency schedules pindolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09854mig. the term pindolol is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules pindolol in its anatomical therapeutic chemical (atc) classification. pindolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pindolol under hs 29339990 and sitc 51577. as of q4 2014, pindolol remains the us fda preferred term for this commodity. pindolol bears us nlm identifiers umls id c0031937 and nci concept code c47673. smiles: o(cc(o)cnc(c)c)c1c2c([nh]cc2)ccc1.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. flusoxolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1gpl60irci. european medicines agency schedules flusoxolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07753mig. flusoxolol generally arises in the molecular formula c22h30fno4. the term flusoxolol is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24.) flusoxolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule flusoxolol under hs 29221980 and sitc 51461. as of q4 2014, flusoxolol remains the us fda preferred term for this commodity. flusoxolol bears us nlm identifiers umls id c0117994 and nci concept code c73018. smiles: fc1ccc(ccoccoc2ccc(occ(o)cnc(c)c)cc2)cc1.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. levomoprolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c13h21no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k4non6fson, chemically known as 2-propanol, 1-(2-methoxyphenoxy)-3-((1-methylethyl)amino)-, (s)- but generally known as levomoprolol, which bears us nih compound identifier 3034006. european medicines agency schedules levomoprolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08480mig. the term levomoprolol is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). levomoprolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule levomoprolol under hs 29221980 and sitc 51461. as of q4 2014, levomoprolol remains the us fda preferred term for this commodity. levomoprolol bears us nlm identifiers umls id c0125658 and nci concept code c83877. smiles: o(cc(o)cnc(c)c)c1c(oc)cccc1.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. mepindolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 00q31er368. european medicines agency schedules mepindolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08750mig. mepindolol generally arises in the molecular formula c15h22n2o2. the term mepindolol is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17.) mepindolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mepindolol under hs 29339990 and sitc 51577. as of q4 2014, mepindolol remains the us fda preferred term for this commodity. mepindolol bears us nlm identifiers umls id c0065961 and nci concept code c84659. smiles: o(cc(o)cnc(c)c)c1c2c([nh]c(c2)c)ccc1.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. prenalterol. this classification denotes an adrenergic beta-1 receptor agonist, cardiotonic agent, and sympathomimetic with the molecular formula c12h19no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m4g34404cx, chemically known as phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, (s)- but generally known as prenalterol, which bears us nih compound identifier 42396. european medicines agency schedules prenalterol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10027mig. world health organization schedules prenalterol in its anatomical therapeutic chemical (atc) classification. prenalterol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule prenalterol under hs 29221980 and sitc 51461. as of q4 2014, prenalterol remains the us fda preferred term for this commodity. smiles: cc(c)ncc(coc1=cc=c(c=c1)o)o.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. procinolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier slj0hil21j. european medicines agency schedules procinolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10060mig. procinolol generally arises in the molecular formula c15h23no2. the term procinolol is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11.) procinolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule procinolol under hs 29221980 and sitc 51461. as of q4 2014, procinolol remains the us fda preferred term for this commodity. procinolol bears us nlm identifiers umls id c0072038 and nci concept code c66471. smiles: o(c1c(c2cc2)cccc1)cc(o)cnc(c)c.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. propranolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c16h21no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9y8nxq24vq, chemically known as 2-propanol, 1- (isopropylamino)-3-(1-naphthyloxy)-, hydrochloride but generally known as propranolol, which bears us nih compound identifier 4946. european medicines agency schedules propranolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10119mig. the term propranolol is an international non-proprietary name. world health organization schedules propranolol in its anatomical therapeutic chemical (atc) classification. propranolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule propranolol under hs 29221980 and sitc 51461. as of q4 2014, propranolol remains the us fda preferred term for this commodity. propranolol bears us nlm identifiers umls id c0033497 and nci concept code c62073. smiles: o(cc(o)cnc(c)c)c1c2c(ccc1)cccc2.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. bopindolol. this classification denotes an adrenergic beta-antagonist with the molecular formula c23h28n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kt304vzo57, chemically known as 2-propanol, 1-((1,1-dimethylethyl)amino)-3-((2-methyl-1h-indol-4-yl)oxy)-, benzoate (ester), (+-)- but generally known as bopindolol, which bears us nih compound identifier 44112. bopindolol most often comes in base and malonate forms. european medicines agency schedules bopindolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05873mig. world health organization schedules bopindolol in its anatomical therapeutic chemical (atc) classification. bopindolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bopindolol under hs 29339990 and sitc 51577. as of q4 2014, bopindolol remains the us fda preferred term for this commodity. smiles: o(c(cnc(c)(c)c)coc1c2c([nh]c(c2)c)ccc1)c(=o)c1ccccc1.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. bopindolol fumarate. this classification denotes an adrenergic beta-antagonist c23h28n2o3.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gm76of8ls3, chemically known as 2-propanol, 1-((1,1-dimethylethyl)amino)-3-((2-methyl-1h-indol-4-yl)oxy)-, 2-benzoate, 2-butenedioate (1:1), but more generally known as bopindolol fumarate, which bears us nih compound identifier 13302095. most nations, for tariff and trade purposes, schedule bopindolol fumarate under hs 29339990 and sitc 51577. as of q4 2014, bopindolol fumarate remains us fdas preferred term for this commodity. smiles: cc1cc2c([nh]1)cccc2occ(cnc(c)(c)c)oc(=o)c3ccccc3.c(=c/c(=o)o)\\c(=o)o.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. bopindolol hydrogen malonate. this classification denotes an adrenergic beta-antagonist with the molecular formula c23h28n2o3.c3h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s3uwr70991, chemically known as propanedioic acid, compd. with (+/-)-2-((1,1-dimethylethyl)amino)-1-(((2-methyl-1h-indol-4-yl)oxy)methyl)ethyl benzoate (1:1), but more generally known as bopindolol hydrogen malonate, which bears us nih compound identifier 636368. european medicines agency schedules bopindolol hydrogen malonate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05873mig. most nations, for tariff purposes, schedule bopindolol hydrogen malonate under hs 29339990. smiles: cc1cc2c([nh]1)cccc2occ(cnc(c)(c)c)oc(=o)c3ccccc3.c(c(=o)o)c(=o)o.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. bopindolol malonate. this classification denotes an adrenergic beta-antagonist c23h28n2o3.c3h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s3uwr70991, chemically known as propanedioic acid, compd. with (+/-)-2-((1,1-dimethylethyl)amino)-1-(((2-methyl-1h-indol-4-yl)oxy)methyl)ethyl benzoate (1:1), but more generally known as bopindolol malonate, which bears us nih compound identifier 636368. european medicines agency schedules bopindolol malonate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00852mig. most nations, for tariff and trade purposes, schedule bopindolol malonate under hs 29339990 and sitc 51577. as of q4 2014, bopindolol malonate remains us fdas preferred term for this commodity. smiles: cc1cc2c([nh]1)cccc2occ(cnc(c)(c)c)oc(=o)c3ccccc3.c(c(=o)o)c(=o)o.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. mepindolol sulfate. this classification denotes a beta-adrenergic blocking agent 2c15h22n2o2.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 63523x4fba, chemically known as 2-propanol, 1-((1-methylethyl)amino)-3-((2-methyl-1h-indol-4-yl)oxy)-, sulfate (2:1), but more generally known as mepindolol sulfate, which bears us nih compound identifier 6917859. european medicines agency schedules mepindolol sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03157mig. most nations, for tariff and trade purposes, schedule mepindolol sulfate under hs 29339990 and sitc 51577. as of q4 2014, mepindolol sulfate remains us fdas preferred term for this commodity. smiles: cc1cc2c([nh]1)cccc2occ(cnc(c)c)o.cc1cc2c([nh]1)cccc2occ(cnc(c)c)o.os(=o)(=o)o.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. prenalterol hydrochloride. this classification denotes an adrenergic beta-1 receptor agonist c12h19no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u6vh18lcq8, chemically known as phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, hydrochloride, (s)-, but more generally known as prenalterol hydrochloride, which bears us nih compound identifier 43590. european medicines agency schedules prenalterol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04029mig. most nations, for tariff and trade purposes, schedule prenalterol hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, prenalterol hydrochloride remains us fdas preferred term for this commodity. smiles: cc(c)nc[c@@h](coc1ccc(cc1)o)o.cl.. "
"adrenergic blocking agent phenoxypropanolamines. this classification denotes adrenergic blocking agents made from compounds based on a propanolamine attached via an oxygen atom to a phenoxy ring. the side chain is one carbon longer than phenylethylamines.. propranolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c16h21no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f8a3652h1v, chemically known as 2-propanol, 1- (isopropylamino)-3-(1-naphthyloxy)-, hydrochloride but more generally known as propranolol hydrochloride, which bears us nih compound identifier 4946. european medicines agency schedules propranolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04091mig. most nations, for tariff and trade purposes, schedule propranolol hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, propranolol hydrochloride remains us fdas preferred term for this commodity. propranolol hydrochloride bears us nlm identifiers umls id c0282321 and nci concept code c29382. smiles: cc(c)ncc(coc1cccc2c1cccc2)o.cl.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. . "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. dapiprazole. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c19h27n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5rnz8gjo7k, chemically known as 5,6,7,8-tetrahydro-3-(2-(4-o-tolyl-1-piperazinyl)ethyl)-s-triazolo(4,3-a)pyridine monohydrochloride but generally known as dapiprazole, which bears us nih compound identifier 91269. european medicines agency schedules dapiprazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06906mig. the term dapiprazole is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules dapiprazole in its anatomical therapeutic chemical (atc) classification. dapiprazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dapiprazole under hs 29335995 and sitc 51576. as of q4 2014, dapiprazole remains the us fda preferred term for this commodity. dapiprazole bears us nlm identifiers umls id c0057143 and nci concept code c83648. smiles: cl.n12ccccc1nnc2ccn1ccn(cc1)c1c(cccc1)c.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. prazosin. this classification denotes an antihypertensive agent and alpha-adrenergic blocking agent with the molecular formula c19h21n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xm03yj541d, chemically known as 4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone but generally known as prazosin, which bears us nih compound identifier 4893. european medicines agency schedules prazosin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10011mig. the term prazosin is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules prazosin in its anatomical therapeutic chemical (atc) classification. prazosin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule prazosin under hs 29349990 and sitc 51579. as of q4 2014, prazosin remains the us fda preferred term for this commodity. prazosin bears us nlm identifiers umls id c0032912 and nci concept code c767. smiles: o=c(n1ccn(cc1)c1nc2c(c(n1)n)cc(oc)c(oc)c2)c1occc1.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. trimazosin. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c20h29n5o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 31l760807h, chemically known as 4-(4-amino-6,7,8-trimethoxy-2-quinazolinyl)-1-piperazinecarboxylic acid, 2-hydroxy-2-methylpropyl ester but generally known as trimazosin, which bears us nih compound identifier 37264. european medicines agency schedules trimazosin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11298mig. the term trimazosin is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). world health organization schedules trimazosin in its anatomical therapeutic chemical (atc) classification. trimazosin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule trimazosin under hs 29335995 and sitc 51576. as of q4 2014, trimazosin remains the us fda preferred term for this commodity. trimazosin bears us nlm identifiers umls id c0077147 and nci concept code c75059. smiles: o(c(=o)n1ccn(cc1)c1nc2c(c(n1)n)cc(oc)c(oc)c2oc)cc(o)(c)c.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. urapidil. this classification denotes an adrenergic alpha-1 receptor antagonist and antihypertensive agent with the molecular formula c20h29n5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a78gf17hjs, chemically known as 2,4(1h,3h)-pyrimidinedione, 6-((3-(4-(2-methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl- (9ci) but generally known as urapidil, which bears us nih compound identifier 5639. european medicines agency schedules urapidil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11384mig. world health organization schedules urapidil in its anatomical therapeutic chemical (atc) classification. urapidil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule urapidil under hs 29335995 and sitc 51576. as of q4 2014, urapidil remains the us fda preferred term for this commodity. smiles: o(c1c(n2ccn(cc2)cccnc2n(c(=o)n(c(=o)c2)c)c)cccc1)c.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. zolertine. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c13h18n6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier emd433ot6a, chemically known as piperazine, 1-phenyl-4-(2-(1h-tetrazol-5-yl)ethyl)- but generally known as zolertine, which bears us nih compound identifier 23669. european medicines agency schedules zolertine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00178mig. the term zolertine is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). zolertine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zolertine under hs 29335995 and sitc 51576. as of q4 2014, zolertine remains the us fda preferred term for this commodity. zolertine bears us nlm identifiers umls id c0078838 and nci concept code c82223. smiles: n1(ccn(cc1)c1ccccc1)ccc1n[nh]nn1.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. terazosin. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c19h25n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8l5014xet7, chemically known as 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine but generally known as terazosin, which bears us nih compound identifier 5401. european medicines agency schedules terazosin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10907mig. the term terazosin is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules terazosin in its anatomical therapeutic chemical (atc) classification. terazosin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule terazosin under hs 29349990 and sitc 51579. as of q4 2014, terazosin remains the us fda preferred term for this commodity. terazosin bears us nlm identifiers umls id c0076107 and nci concept code c61964. smiles: o1c(ccc1)c(=o)n1ccn(cc1)c1nc2c(c(n1)n)cc(oc)c(oc)c2.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. dapiprazole hydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c19h27n5.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ds9ujn1i0x, chemically known as 5,6,7,8-tetrahydro-3-(2-(4-o-tolyl-1-piperazinyl)ethyl)-s-triazolo(4,3-a)pyridine monohydrochloride but more generally known as dapiprazole hydrochloride, which bears us nih compound identifier 91269. european medicines agency schedules dapiprazole hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01554mig. most nations, for tariff and trade purposes, schedule dapiprazole hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, dapiprazole hydrochloride remains us fdas preferred term for this commodity. dapiprazole hydrochloride bears us nlm identifiers umls id c0770916 and nci concept code c47469. smiles: cc1ccccc1n2ccn(cc2)ccc3nnc4n3cccc4.cl.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. dapiprazole monohydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c19h27n5.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ds9ujn1i0x, chemically known as 1,2,4-triazolo(4,3-a)pyridine, 5,6,7,8-tetrahydro-3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-, monohydrochloride, but more generally known as dapiprazole monohydrochloride, which bears us nih compound identifier 91269. european medicines agency schedules dapiprazole monohydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06906mig. most nations, for tariff purposes, schedule dapiprazole monohydrochloride under hs 29335995. smiles: cc1ccccc1n2ccn(cc2)ccc3nnc4n3cccc4.cl.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. prazosin hydrochloride. this classification denotes an antihypertensive agent and alpha-adrenergic blocking agent with the molecular formula c19h21n5o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x0z7454b90, chemically known as 4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone but more generally known as prazosin hydrochloride, which bears us nih compound identifier 4893. european medicines agency schedules prazosin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04013mig. most nations, for tariff and trade purposes, schedule prazosin hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, prazosin hydrochloride remains us fdas preferred term for this commodity. prazosin hydrochloride bears us nlm identifiers umls id c0700578 and nci concept code c1507. smiles: coc1cc2c(cc1oc)nc(nc2n)n3ccn(cc3)c(=o)c4ccco4.cl.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. terazosin hydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c19h25n5o4.clh.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d32s14f082, chemically known as 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine but more generally known as terazosin hydrochloride, which bears us nih compound identifier 5401. european medicines agency schedules terazosin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04722mig. most nations, for tariff and trade purposes, schedule terazosin hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, terazosin hydrochloride remains us fdas preferred term for this commodity. terazosin hydrochloride bears us nlm identifiers umls id c0770137 and nci concept code c29491. smiles: coc1cc2c(cc1oc)nc(nc2n)n3ccn(cc3)c(=o)c4ccco4.o.o.cl.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. terazosin hydrochloride anhydrous. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c19h25n5o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8qop8z9955. european medicines agency schedules terazosin hcl in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04722mig. most nations, for tariff and trade purposes, schedule terazosin hydrochloride anhydrous under hs 29349990 and sitc 51579. as of q4 2014, terazosin hydrochloride anhydrous remains us fdas preferred term for this commodity. terazosin hydrochloride anhydrous bears us nlm identifiers umls id c2241271 and nci concept code c75056. smiles: coc1cc2c(cc1oc)nc(nc2n)n3ccn(cc3)c(=o)c4ccco4.cl.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. terazosin hydrochloride dihydrate. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c19h25n5o4.clh.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d32s14f082, chemically known as 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine but more generally known as terazosin hydrochloride dihydrate, which bears us nih compound identifier 5401. european medicines agency schedules terazosin hydrochloride dihydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04722mig. most nations, for tariff and trade purposes, schedule terazosin hydrochloride dihydrate under hs 29349990. smiles: coc1cc2c(cc1oc)nc(nc2n)n3ccn(cc3)c(=o)c4ccco4.o.o.cl.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. terazosin monohydrochloride dihydrate. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c19h25n5o4.clh.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d32s14f082, chemically known as methanone, (4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl)(tetrahydro-2-furanyl)-, hydrochloride, hydrate (1:1:2), but more generally known as terazosin monohydrochloride dihydrate, which bears us nih compound identifier 63016. european medicines agency schedules terazosin monohydrochloride dihydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10907mig. most nations, for tariff purposes, schedule terazosin monohydrochloride dihydrate under hs 29349990. smiles: coc1cc2c(cc1oc)nc(nc2n)n3ccn(cc3)c(=o)c4ccco4.o.o.cl.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. trimazosin hydrochloride. this classification denotes the hydrochloride form of an alpha-adrenergic blocking agent with the molecular formula c20h29n5o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 31l760807h, chemically known as 4-(4-amino-6,7,8-trimethoxy-2-quinazolinyl)-1-piperazinecarboxylic acid, 2-hydroxy-2-methylpropyl ester but more generally known as trimazosin, which bears us nih compound identifier 37264. european medicines agency schedules trimazosin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11298mig. the term trimazosin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 28, no. 10 1974, list 14). world health organization schedules trimazosin in its anatomical therapeutic chemical (atc) classification. trimazosin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule trimazosin hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, trimazosin hydrochloride remains us fdas preferred term for this commodity. trimazosin hydrochloride bears us nlm identifiers umls id c0888485 and nci concept code c75060. smiles: cc(c)(coc(=o)n1ccn(cc1)c2nc3c(cc(c(c3oc)oc)oc)c(n2)n)o.o.cl.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. trimazosin hydrochloride anhydrous. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c20h29n5o6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ot29p74170, chemically known as 1-piperazinecarboxylic acid, 4-(4-amino-6,7,8-trimethoxy-2-quinazolinyl)-, 2-hydroxy-2-methylpropyl ester, hydrochloride (1:1), but more generally known as trimazosin hydrochloride anhydrous, which bears us nih compound identifier 64748. european medicines agency schedules trimazosin hydrochloride anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11298mig. most nations, for tariff purposes, schedule trimazosin hydrochloride anhydrous under hs 29335995. smiles: cc(c)(coc(=o)n1ccn(cc1)c2nc3c(cc(c(c3oc)oc)oc)c(n2)n)o.cl.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. urapidil fumarate. this classification denotes an adrenergic alpha-1 receptor antagonist and antihypertensive agent c20h29n5o3.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7565zxn22a, chemically known as 6-((3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)amino)-1,3-dimethylpyrimidine-2,4(1h,3h)-dione (2e)-but-2-enedioate (1:1), but more generally known as urapidil fumarate, which bears us nih compound identifier 9870716. most nations, for tariff and trade purposes, schedule urapidil fumarate under hs 29335995 and sitc 51576. as of q4 2014, urapidil fumarate remains us fdas preferred term for this commodity. smiles: cn1c(cc(=o)n(c1=o)c)ncccn2ccn(cc2)c3ccccc3oc.c(=c/c(=o)o)\\c(=o)o.. "
"adrenergic blocking agent piperazines. this classification denotes adrenergic blocking agents made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. zolertine hydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c13h18n6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bm71fqz25g, chemically known as piperazine, 1-phenyl-4-(2-(1h-tetrazol-5-yl)ethyl)- but more generally known as zolertine hydrochloride, which bears us nih compound identifier 23669. most nations, for tariff and trade purposes, schedule zolertine hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, zolertine hydrochloride remains us fdas preferred term for this commodity. zolertine hydrochloride bears us nlm identifiers umls id c2826060 and nci concept code c82224. smiles: c1ccc(cc1)n2ccn(cc2)ccc3[nh]nnn3.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. . "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. atenolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c14h22n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 50vv3vw0ti, chemically known as ici 66,082 but generally known as atenolol, which bears us nih compound identifier 2249. atenolol comes in many forms, including base, acetate, acid, diacetate, hydrochloride, methylboronate, and n-butylboronate. european medicines agency schedules atenolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05590mig. the term atenolol is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules atenolol in its anatomical therapeutic chemical (atc) classification. atenolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule atenolol under hs 29242995 and sitc 51479. as of q4 2014, atenolol remains the us fda preferred term for this commodity. atenolol bears us nlm identifiers umls id c0004147 and nci concept code c28836. smiles: o(cc(o)cnc(c)c)c1ccc(cc1)cc(=o)n.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. arotinolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c15h21n3o2s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 394e3p3b99, chemically known as 5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-2-thiophenecarboxamide but generally known as arotinolol, which bears us nih compound identifier 2239. arotinolol most often comes in base and hydrochloride forms. european medicines agency schedules arotinolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05568mig. the term arotinolol is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). arotinolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule arotinolol under hs 29341000 and sitc 51579. as of q4 2014, arotinolol remains the us fda preferred term for this commodity. arotinolol bears us nlm identifiers umls id c0104221 and nci concept code c72609. smiles: s(cc(o)cnc(c)(c)c)c1scc(n1)c1sc(cc1)c(=o)n.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. adimolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c25h29n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b6cjy5k2st, chemically known as (rs)-2,3-dihydro-1-(3-(2-hydroxy-3-(naphthyloxy)propylamino)-3-methylbutyl)-1h-2-benzimidazolon but generally known as adimolol, which bears us nih compound identifier 71227. adimolol most often comes in forms base, hydrochloride, and hydrate. european medicines agency schedules adimolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05270mig. the term adimolol is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). adimolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule adimolol under hs 29339990 and sitc 51577. as of q4 2014, adimolol remains the us fda preferred term for this commodity. adimolol bears us nlm identifiers umls id c0050843 and nci concept code c73013. smiles: oc(cnc(ccn1c2c([nh]c1=o)cccc2)(c)c)coc1c2c(ccc1)cccc2.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. alprenolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c15h23no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 877k5mq27w, chemically known as 2-propanol, 1-(o-allylphenoxy)-3-(isopropylamino)- but generally known as alprenolol, which bears us nih compound identifier 2119. alprenolol most often comes in glucuronide and hydrochloride forms. european medicines agency schedules alprenolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05371mig. the term alprenolol is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules alprenolol in its anatomical therapeutic chemical (atc) classification. alprenolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule alprenolol under hs 29221980 and sitc 51461. as of q4 2014, alprenolol remains the us fda preferred term for this commodity. alprenolol bears us nlm identifiers umls id c0002334 and nci concept code c81653. smiles: o(cc(o)cnc(c)c)c1c(cc=c)cccc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bisoprolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c18h31no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y41js2nl6u, chemically known as 2-propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)- but generally known as bisoprolol, which bears us nih compound identifier 2405. bisoprolol most often comes in base and fumarate forms. european medicines agency schedules bisoprolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13096mig. the term bisoprolol is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules bisoprolol in its anatomical therapeutic chemical (atc) classification. bisoprolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bisoprolol under hs 29221980 and sitc 51461. as of q4 2014, bisoprolol remains the us fda preferred term for this commodity. bisoprolol bears us nlm identifiers umls id c0053799 and nci concept code c61653. smiles: o(cc(o)cnc(c)c)c1ccc(coccoc(c)c)cc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. carteolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c16h24n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8nf31401xg, chemically known as 2(1h)-quinolinone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro- but generally known as carteolol, which bears us nih compound identifier 2583. carteolol most often comes in base and hydrochloride forms. european medicines agency schedules carteolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06150mig. the term carteolol is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules carteolol in its anatomical therapeutic chemical (atc) classification. carteolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carteolol under hs 29337900 and sitc 51561. as of q4 2014, carteolol remains the us fda preferred term for this commodity. carteolol bears us nlm identifiers umls id c0007299 and nci concept code c65291. smiles: o(cc(o)cnc(c)(c)c)c1c2ccc(=o)nc2ccc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. befunolol. this classification denotes a beta-adrenergic blocking agent and anti-glaucoma agent with the molecular formula c16h21no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 418546mt3a, chemically known as ketone, 7-(2-hydroxy-3-(isopropylamino)propoxy)-2-benzofuranyl methyl but generally known as befunolol, which bears us nih compound identifier 2309. befunolol most often comes in base and hydrochloride forms. european medicines agency schedules befunolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05682mig. the term befunolol is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules befunolol in its anatomical therapeutic chemical (atc) classification. befunolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule befunolol under hs 29329985 and sitc 51569. as of q4 2014, befunolol remains the us fda preferred term for this commodity. befunolol bears us nlm identifiers umls id c0053071 and nci concept code c73021. smiles: o(cc(o)cnc(c)c)c1c2oc(cc2ccc1)c(=o)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. betaxolol or levobetaxolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c18h29no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o0zr1r6rz2, chemically known as 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)- but generally known as betaxolol, which bears us nih compound identifier 2369. betaxolol most often comes in base and hydrochloride forms. european medicines agency schedules betaxolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05804mig. the term betaxolol is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules betaxolol in its anatomical therapeutic chemical (atc) classification. betaxolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. betaxolol or levobetaxolol bears us nlm identifiers umls id c0005320 and nci concept code c61652. smiles: o(cc1cc1)ccc1ccc(occ(o)cnc(c)c)cc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bevantolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c20h27no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 34zxw6zv21, chemically known as 2-propanol, 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)- but generally known as bevantolol, which bears us nih compound identifier 2372. bevantolol most often comes in base, hydrochloride, and metabolite forms. european medicines agency schedules bevantolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05808mig. the term bevantolol is an international non-proprietary name. world health organization schedules bevantolol in its anatomical therapeutic chemical (atc) classification. bevantolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bevantolol under hs 29225000 and sitc 51467. as of q4 2014, bevantolol remains the us fda preferred term for this commodity. bevantolol bears us nlm identifiers umls id c0053532 and nci concept code c79556. smiles: o(cc(o)cnccc1cc(oc)c(oc)cc1)c1cc(ccc1)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. idropranolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c16h23no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5u6118qyhk, chemically known as 1-((5,6-dihydro-1-naphthyl)oxy)-3-(isopropylamino)-2-propanol but generally known as idropranolol, which bears us nih compound identifier 163314. european medicines agency schedules idropranolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08122mig. the term idropranolol is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). idropranolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule idropranolol under hs 29221980 and sitc 51461. as of q4 2014, idropranolol remains the us fda preferred term for this commodity. idropranolol bears us nlm identifiers umls id c2827192 and nci concept code c83781. smiles: o(cc(o)cnc(c)c)c1c2c(ccc=c2)ccc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bornaprolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 66sts87gey. european medicines agency schedules bornaprolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05875mig. bornaprolol generally arises in the molecular formula c19h29no2. the term bornaprolol is an international non-proprietary name or inn. bornaprolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bornaprolol under hs 29221980 and sitc 51461. as of q4 2014, bornaprolol remains the us fda preferred term for this commodity. bornaprolol bears us nlm identifiers umls id c0106915 and nci concept code c90794. smiles: o(c1c(c2c3cc(c2)cc3)cccc1)cc(o)cnc(c)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bucindolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c22h25n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e9uo06k7ce, chemically known as 2-(2-hydroxy-3-((2-(1h-indol-3-yl)-1,1-dimethylethyl)amino)propoxy)benzonitrile but generally known as bucindolol, which bears us nih compound identifier 51045. bucindolol most often comes in base and hydrochloride forms. european medicines agency schedules bucindolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05945mig. the term bucindolol is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). bucindolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bucindolol under hs 29339990 and sitc 51577. as of q4 2014, bucindolol remains the us fda preferred term for this commodity. bucindolol bears us nlm identifiers umls id c0054196 and nci concept code c79557. smiles: oc(cnc(cc1c2c([nh]c1)cccc2)(c)c)coc1c(cccc1)c#n.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bucumolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c17h23no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u8wvj3501l, chemically known as 8-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-5-methyl-2h-1-benzopyran-2-one but generally known as bucumolol, which bears us nih compound identifier 169787. bucumolol most often comes in base and hydrochloride forms. european medicines agency schedules bucumolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05954mig. the term bucumolol is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). bucumolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, bucumolol remains the us fda preferred term for this commodity. bucumolol bears us nlm identifiers umls id c0054199 and nci concept code c72611. smiles: o(cc(o)cnc(c)(c)c)c1c2oc(=o)ccc2c(cc1)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bunitrolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c14h20n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f2613lo055, chemically known as 2-propanol, 3-(tert-butylamino)-1-(m-cyanophenoxy)- but generally known as bunitrolol, which bears us nih compound identifier 2473. bunitrolol most often comes in base and hydrochloride forms. european medicines agency schedules bunitrolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05978mig. the term bunitrolol is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). bunitrolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bunitrolol under hs 29269095 and sitc 51484. as of q4 2014, bunitrolol remains the us fda preferred term for this commodity. bunitrolol bears us nlm identifiers umls id c0006387 and nci concept code c72614. smiles: oc(cnc(c)(c)c)coc1c(cccc1)c#n.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bupranolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c14h22clno2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 858ygi5pit, chemically known as 2-propanol, 1-(tert-butylamino)-3-((6-chloro-m-tolyl)oxy)- (8ci) but generally known as bupranolol, which bears us nih compound identifier 2475. bupranolol most often comes in base and hydrochloride forms. european medicines agency schedules bupranolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05984mig. the term bupranolol is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules bupranolol in its anatomical therapeutic chemical (atc) classification. bupranolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bupranolol under hs 29221980 and sitc 51461. as of q4 2014, bupranolol remains the us fda preferred term for this commodity. bupranolol bears us nlm identifiers umls id c0006403 and nci concept code c72615. smiles: clc1c(occ(o)cnc(c)(c)c)cc(cc1)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. butofilolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c17h26fno3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4azc6y5a8g, chemically known as 1-butanone, 1-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-5-fluorophenyl)- but generally known as butofilolol, which bears us nih compound identifier 68838. butofilolol most often comes in base and maleate forms. european medicines agency schedules butofilolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06029mig. the term butofilolol is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). butofilolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule butofilolol under hs 29221980 and sitc 51461. as of q4 2014, butofilolol remains the us fda preferred term for this commodity. butofilolol bears us nlm identifiers umls id c0054262 and nci concept code c77940. smiles: fc1cc(c(occ(o)cnc(c)(c)c)cc1)c(=o)ccc.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. carazolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c18h22n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 29pw75s82a, chemically known as 2-propanol, 1-(9h-carbazol-4-yloxy)-3-((1-methylethyl)amino)- but generally known as carazolol, which bears us nih compound identifier 71739. carazolol most often comes in base, glucuronide, and hydrochloride forms. european medicines agency schedules carazolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06086mig. the term carazolol is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). carazolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carazolol under hs 29339990 and sitc 51577. as of q4 2014, carazolol remains the us fda preferred term for this commodity. carazolol bears us nlm identifiers umls id c0054636 and nci concept code c77941. smiles: o(c1c2c3c([nh]c2ccc1)cccc3)cc(o)cnc(c)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. nicainoprol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c21h27n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1ua960p80h, chemically known as 1,2,3,4-tetrahydro-8-(2-hydroxy-3-(isopropylamino)propoxy)-1-(3-pyridylcarbonyl)quinoline but generally known as nicainoprol, which bears us nih compound identifier 71147. european medicines agency schedules nicainoprol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09221mig. the term nicainoprol is an international non-proprietary name. nicainoprol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nicainoprol under hs 29334990 and sitc 51575. as of q4 2014, nicainoprol remains the us fda preferred term for this commodity. nicainoprol bears us nlm identifiers umls id c0068676 and nci concept code c76553. smiles: o(c1c2n(cccc2ccc1)c(=o)c1cccnc1)cc(o)cnc(c)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. cicloprolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c18h29no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1k2ach4u3r, chemically known as 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethoxy)phenoxy)-3-((1-methylethyl)amino)- but generally known as cicloprolol, which bears us nih compound identifier 146294. european medicines agency schedules cicloprolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06248mig. the term cicloprolol is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). cicloprolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cicloprolol under hs 29221980 and sitc 51461. as of q4 2014, cicloprolol remains the us fda preferred term for this commodity. cicloprolol bears us nlm identifiers umls id c0055713 and nci concept code c79559. smiles: o(cc1cc1)ccoc1ccc(occ(o)cnc(c)c)cc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. cloranolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c13h19cl2no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q3u058h86v, chemically known as 2-propanol, 1-(2,5-dichlorophenoxy)-3-((1,1-dimethylethyl)amino)- but generally known as cloranolol, which bears us nih compound identifier 65814. european medicines agency schedules cloranolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06752mig. the term cloranolol is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). world health organization schedules cloranolol in its anatomical therapeutic chemical (atc) classification. cloranolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cloranolol under hs 29221980 and sitc 51461. as of q4 2014, cloranolol remains the us fda preferred term for this commodity. cloranolol bears us nlm identifiers umls id c0076772 and nci concept code c81658. smiles: clc1c(occ(o)cnc(c)(c)c)cc(cl)cc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. epanolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c20h23n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9kgc55kp6a, chemically known as benzeneacetamide, n-(2-((3-(2-cyanophenoxy)-2-hydroxypropyl)amino)ethyl)-4-hydroxy- but generally known as epanolol, which bears us nih compound identifier 72014. european medicines agency schedules epanolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06558mig. the term epanolol is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules epanolol in its anatomical therapeutic chemical (atc) classification. epanolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule epanolol under hs 29269095 and sitc 51484. as of q4 2014, epanolol remains the us fda preferred term for this commodity. epanolol bears us nlm identifiers umls id c0116294 and nci concept code c72616. smiles: oc(cnccnc(=o)cc1ccc(o)cc1)coc1c(cccc1)c#n.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. esmolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c16h25no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mdy902uxsr, chemically known as benzenepropanoic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, methyl ester but generally known as esmolol, which bears us nih compound identifier 59768. european medicines agency schedules esmolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13718mig. the term esmolol is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). world health organization schedules esmolol in its anatomical therapeutic chemical (atc) classification. esmolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule esmolol under hs 29221980 and sitc 51461. as of q4 2014, esmolol remains the us fda preferred term for this commodity. esmolol bears us nlm identifiers umls id c0116569 and nci concept code c72617. smiles: o(cc(o)cnc(c)c)c1ccc(ccc(=o)oc)cc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. primidolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c17h23n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 56qh73d78k, chemically known as 2,4-(1h,3h)-pyrimidinedione, 1-(2-((2-hydroxy-3-(2-methylphenoxy)propyl)amino)ethyl)-5-methyl- but generally known as primidolol, which bears us nih compound identifier 68563. european medicines agency schedules primidolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10044mig. the term primidolol is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). primidolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule primidolol under hs 29335995 and sitc 51576. as of q4 2014, primidolol remains the us fda preferred term for this commodity. primidolol bears us nlm identifiers umls id c0071975 and nci concept code c76557. smiles: o(cc(o)cnccn1cc(c(=o)[nh]c1=o)c)c1c(cccc1)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. indopanolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2jq3661cad. european medicines agency schedules indopanolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08181mig. indopanolol generally arises in the molecular formula c20h23cln2o3. the term indopanolol is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23.) indopanolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule indopanolol under hs 29339990 and sitc 51577. as of q4 2014, indopanolol remains the us fda preferred term for this commodity. indopanolol bears us nlm identifiers umls id c1881198 and nci concept code c65914. smiles: clc1(c2c(occ(o)cnccoc3ccccc3)cccc2n=c1)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. levobunolol. this classification denotes a beta-adrenergic blocking agent and anti-glaucoma agent with the molecular formula c17h25no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g6317aoi7k, chemically known as 3,4-dihydro-5-(3-(tert-butylamino)-2-hydroxy)propoxy-1(2h)-naphthalenone but generally known as levobunolol, which bears us nih compound identifier 3914. european medicines agency schedules levobunolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08463mig. the term levobunolol is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules levobunolol in its anatomical therapeutic chemical (atc) classification. levobunolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule levobunolol under hs 29221980 and sitc 51461. as of q4 2014, levobunolol remains the us fda preferred term for this commodity. levobunolol bears us nlm identifiers umls id c0006388 and nci concept code c62043. smiles: o(c1c2cccc(=o)c2ccc1)cc(o)cnc(c)(c)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. metipranolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c17h27no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x39al81keb, chemically known as 4-(2-hydroxy-3-((1-methylethyl)-amino)propoxy)-2,3,6-trimethylphenol 1-acetate but generally known as metipranolol, which bears us nih compound identifier 31477. european medicines agency schedules metipranolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08892mig. the term metipranolol is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules metipranolol in its anatomical therapeutic chemical (atc) classification. metipranolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule metipranolol under hs 29221980 and sitc 51461. as of q4 2014, metipranolol remains the us fda preferred term for this commodity. metipranolol bears us nlm identifiers umls id c0041030 and nci concept code c61844. smiles: o(cc(o)cnc(c)c)c1c(c(c(oc(=o)c)c(c1)c)c)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. talinolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c20h33n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3s82268bkg, chemically known as urea, n-cyclohexyl-n-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)- but generally known as talinolol, which bears us nih compound identifier 68770. european medicines agency schedules talinolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10804mig. the term talinolol is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). world health organization schedules talinolol in its anatomical therapeutic chemical (atc) classification. talinolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule talinolol under hs 29242190 and sitc 51473. as of q4 2014, talinolol remains the us fda preferred term for this commodity. talinolol bears us nlm identifiers umls id c0075783 and nci concept code c73020. smiles: o=c(nc1ccccc1)nc1ccc(occ(o)cnc(c)(c)c)cc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. nipradilol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c15h22n2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fvm336i71y, chemically known as 3,4-dihydro-8-(2-hydroxy-3-isopropylamino)propoxy-3-nitroxy-2h-1-benzopyran but generally known as nipradilol, which bears us nih compound identifier 72006. european medicines agency schedules nipradilol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12423mig. the term nipradilol is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). nipradilol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nipradilol under hs 29329985 and sitc 51569. as of q4 2014, nipradilol remains the us fda preferred term for this commodity. nipradilol bears us nlm identifiers umls id c0132531 and nci concept code c76555. smiles: o1cc(o[n](=o)o)cc2c1c(occ(o)cnc(c)c)ccc2.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. oxprenolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c15h23no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 519mxn9yzr, chemically known as 2-propanol, 1-(2-allyloxyphenoxy)-3-(isopropylamino)- but generally known as oxprenolol, which bears us nih compound identifier 4631. european medicines agency schedules oxprenolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09555mig. the term oxprenolol is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). world health organization schedules oxprenolol in its anatomical therapeutic chemical (atc) classification. oxprenolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxprenolol under hs 29221980 and sitc 51461. as of q4 2014, oxprenolol remains the us fda preferred term for this commodity. oxprenolol bears us nlm identifiers umls id c0030040 and nci concept code c66276. smiles: o(cc(o)cnc(c)c)c1c(occ=c)cccc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. pacrinolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c23h28n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier che211jzxq, chemically known as (-)-p-(3-((3,4-dimethoxyphenetyl)amino)-2-hydroxypropoxy)-beta-methylcinnamonitrile but generally known as pacrinolol, which bears us nih compound identifier 6436098. european medicines agency schedules pacrinolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09584mig. the term pacrinolol is an international non-proprietary name. pacrinolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pacrinolol under hs 29269095 and sitc 51484. as of q4 2014, pacrinolol remains the us fda preferred term for this commodity. pacrinolol bears us nlm identifiers umls id c0135043 and nci concept code c90800. smiles: o(cc(o)cnccc1cc(oc)c(oc)cc1)c1ccc(cc1)/c(=c/c#n)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. pafenolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5aep5yj9mz. european medicines agency schedules pafenolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09585mig. pafenolol generally arises in the molecular formula c18h31n3o3. the term pafenolol is an international non-proprietary name or inn. pafenolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pafenolol under hs 29242190 and sitc 51473. as of q4 2014, pafenolol remains the us fda preferred term for this commodity. pafenolol bears us nlm identifiers umls id c0069942 and nci concept code c66291. smiles: o(cc(o)cnc(c)c)c1ccc(ccnc(=o)nc(c)c)cc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. pargolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5opo851w5l. european medicines agency schedules pargolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09625mig. pargolol generally arises in the molecular formula c16h23no3. the term pargolol is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17.) pargolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pargolol under hs 29221980 and sitc 51461. as of q4 2014, pargolol remains the us fda preferred term for this commodity. pargolol bears us nlm identifiers umls id c0070112 and nci concept code c66321. smiles: oc(cnc(c)(c)c)coc1c(occ#c)cccc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. penbutolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 78w62v43dy. european medicines agency schedules penbutolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09660mig. penbutolol generally arises in the molecular formula c18h29no2. the term penbutolol is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11.) penbutolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule penbutolol under hs 29221980 and sitc 51461. as of q4 2014, penbutolol remains the us fda preferred term for this commodity. penbutolol bears us nlm identifiers umls id c0030812 and nci concept code c66336. smiles: o(c1c(c2cccc2)cccc1)cc(o)cnc(c)(c)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. practolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c14h22n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sug9176grw, chemically known as acetanilide, 4-(2-hydroxy-3-(isopropylamino)propoxy)- but generally known as practolol, which bears us nih compound identifier 4883. european medicines agency schedules practolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09986mig. the term practolol is an international non-proprietary name. world health organization schedules practolol in its anatomical therapeutic chemical (atc) classification. practolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule practolol under hs 29242995 and sitc 51479. as of q4 2014, practolol remains the us fda preferred term for this commodity. practolol bears us nlm identifiers umls id c0032896 and nci concept code c76556. smiles: o(cc(o)cnc(c)c)c1ccc(nc(=o)c)cc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. tertatolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c16h25no2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9zo341yqxp, chemically known as 2-propanol, 1-((3,4-dihydro-2h-1-benzothiopyran-8-yl)oxy)-3-((1,1-dimethylethyl)amino)- but generally known as tertatolol, which bears us nih compound identifier 36920. european medicines agency schedules tertatolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10933mig. the term tertatolol is an international non-proprietary name. world health organization schedules tertatolol in its anatomical therapeutic chemical (atc) classification. tertatolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tertatolol under hs 29349990 and sitc 51579. as of q4 2014, tertatolol remains the us fda preferred term for this commodity. tertatolol bears us nlm identifiers umls id c0076166 and nci concept code c81654. smiles: s1c2c(ccc1)cccc2occ(o)cnc(c)(c)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. timolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula 2c13h24n4o3s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 817w3c6175, chemically known as 2-propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)-oxy)-, (+-)- but generally known as timolol, which bears us nih compound identifier 5478. european medicines agency schedules timolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11069mig. world health organization schedules timolol in its anatomical therapeutic chemical (atc) classification. timolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule timolol under hs 29349990 and sitc 51579. as of q4 2014, timolol remains the us fda preferred term for this commodity. timolol bears us nlm identifiers umls id c0040233 and nci concept code c47757. smiles: cc(c)(c)ncc(coc1=nsn=c1n2ccocc2)o.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. xipranolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c23h33no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zji41p5wmh, chemically known as 2-propanol, 1-(di-2,6-xylylmethoxy)-3-(isopropylamino)- but generally known as xipranolol, which bears us nih compound identifier 65692. european medicines agency schedules xipranolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00117mig. the term xipranolol is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). xipranolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule xipranolol under hs 29221980 and sitc 51461. as of q4 2014, xipranolol remains the us fda preferred term for this commodity. xipranolol bears us nlm identifiers umls id c0601010 and nci concept code c66672. smiles: o(c(c1c(cccc1c)c)c1c(cccc1c)c)cc(o)cnc(c)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. acebutolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c18h28n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 67p356d8gh, chemically known as butanamide, n-(3-acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-,monohydrochloride,( -)- but generally known as acebutolol, which bears us nih compound identifier 1978. acebutolol most often comes in forms base, azide, hydrochloride, and methylboronate. european medicines agency schedules acebutolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07371mig. the term acebutolol is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). world health organization schedules acebutolol in its anatomical therapeutic chemical (atc) classification. acebutolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule acebutolol under hs 29242995 and sitc 51479. as of q4 2014, acebutolol remains the us fda preferred term for this commodity. acebutolol bears us nlm identifiers umls id c0000946 and nci concept code c61525. smiles: o(cc(o)cnc(c)c)c1c(cc(nc(=o)ccc)cc1)c(=o)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. metoprolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c15h25no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier geb06nhm23, chemically known as 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)- but generally known as metoprolol, which bears us nih compound identifier 4171. european medicines agency schedules metoprolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14568mig. the term metoprolol is an international non-proprietary name. world health organization schedules metoprolol in its anatomical therapeutic chemical (atc) classification. metoprolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule metoprolol under hs 29221980 and sitc 51461. as of q4 2014, metoprolol remains the us fda preferred term for this commodity. metoprolol bears us nlm identifiers umls id c0025859 and nci concept code c61845. smiles: o(cc(o)cnc(c)c)c1ccc(ccoc)cc1.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. celiprolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c20h33n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier drb57k47qc, chemically known as urea, n-(3-acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-n,n-diethyl- but generally known as celiprolol, which bears us nih compound identifier 2663. european medicines agency schedules celiprolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07436mig. the term celiprolol is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). world health organization schedules celiprolol in its anatomical therapeutic chemical (atc) classification. celiprolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule celiprolol under hs 29242190 and sitc 51473. as of q4 2014, celiprolol remains the us fda preferred term for this commodity. celiprolol bears us nlm identifiers umls id c0055021 and nci concept code c79558. smiles: o(cc(o)cnc(c)(c)c)c1c(cc(nc(=o)n(cc)cc)cc1)c(=o)c.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. esatenolol or s-atenolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c14h22n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dpf757bosr, chemically known as 2-[4-[(2s)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide but generally known as s-atenolol or esatenolol, which bears us nih compound identifier 175540. european medicines agency schedules s-atenolol or esatenolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06608mig. the term esatenolol is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 3 1997, list 38.). world health organization schedules esatenolol in its anatomical therapeutic chemical (atc) classification. esatenolol or s-atenolol bears us nlm identifiers umls id c2825715 and nci concept code c81661. smiles: cc(c)ncc(coc1=cc=c(c=c1)cc(=o)n)o.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. flestolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c15h22fn3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier li02075e1w, chemically known as [3-[[1-(carbamoylamino)-2-methylpropan-2-yl]amino]-2-hydroxypropyl]2-fluorobenzoate but generally known as flestolol, which bears us nih compound identifier 55885. european medicines agency schedules flestolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07641mig. most nations schedule flestolol under hs 29242190 and sitc 51473. as of q4 2014, flestolol remains the us fda preferred term for this commodity. flestolol bears us nlm identifiers umls id c0060455 and nci concept code c72784. smiles: cc(c)(cnc(=o)n)ncc(coc(=o)c1=cc=cc=c1f)o.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. acebutolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c18h28n2o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b025y34c54, chemically known as m&b 17,803a but more generally known as acebutolol hydrochloride, which bears us nih compound identifier 36816. the base preparation, acebutolol, also comes in forms base, azide, and methylboronate. european medicines agency schedules acebutolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00240mig. most nations, for tariff and trade purposes, schedule acebutolol hydrochloride under hs 29242995 and sitc 51479. as of q4 2014, acebutolol hydrochloride remains us fdas preferred term for this commodity. acebutolol hydrochloride bears us nlm identifiers umls id c0543447 and nci concept code c28806. smiles: cccc(=o)nc1ccc(c(c1)c(=o)c)occ(cnc(c)c)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. alprenolol benzoate. this classification denotes a beta-adrenergic blocking agent c15h23no2.c7h6o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t3h696761c, chemically known as benzoic acid, compd. with 1-((1-methylethyl)amino)-3-(2-(2-propenyl)phenoxy)-2-propanol (1:1), but more generally known as alprenolol benzoate, which bears us nih compound identifier 9951320. european medicines agency schedules alprenolol benzoate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00377mig. most nations, for tariff and trade purposes, schedule alprenolol benzoate under hs 29221980 and sitc 51461. as of q4 2014, alprenolol benzoate remains us fdas preferred term for this commodity. smiles: cc(c)ncc(coc1ccccc1cc=c)o.c1ccc(cc1)c(=o)o.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. alprenolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c15h23no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2502c2oirk, chemically known as 2-propanol, 1-(o-allylphenoxy)-3-(isopropylamino)-, hydrochloride but more generally known as alprenolol hydrochloride, which bears us nih compound identifier 66368. european medicines agency schedules alprenolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00378mig. most nations, for tariff and trade purposes, schedule alprenolol hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, alprenolol hydrochloride remains us fdas preferred term for this commodity. alprenolol hydrochloride bears us nlm identifiers umls id c0282044 and nci concept code c81651. smiles: cc(c)ncc(coc1ccccc1cc=c)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. arotinolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c15h21n3o2s3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9doi1ht306, chemically known as 2-thiophenecarboxamide, 5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-, monohydrochloride, (+-)- but more generally known as arotinolol hydrochloride, which bears us nih compound identifier 155032. european medicines agency schedules arotinolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00590mig. most nations, for tariff and trade purposes, schedule arotinolol hydrochloride under hs 29341000 and sitc 51579. as of q4 2014, arotinolol hydrochloride remains us fdas preferred term for this commodity. smiles: cc(c)(c)ncc(csc1nc(cs1)c2ccc(s2)c(=o)n)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. atenolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c14h22n2o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6di0ut7u1q, chemically known as benzeneacetamide, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, monohydrochloride but more generally known as atenolol hydrochloride, which bears us nih compound identifier 119274. european medicines agency schedules atenolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00615mig. most nations, for tariff and trade purposes, schedule atenolol hydrochloride under hs 29242995 and sitc 51479. as of q4 2014, atenolol hydrochloride remains us fdas preferred term for this commodity. smiles: cc(c)ncc(coc1ccc(cc1)cc(=o)n)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. befunolol hydrochloride. this classification denotes a beta-adrenergic blocking agent and anti-glaucoma agent with the molecular formula c16h21no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b03z2vy37i, chemically known as ethanone, 1-(7-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-2-benzofuranyl)-, hydrochloride but more generally known as befunolol hydrochloride, which bears us nih compound identifier 38286. european medicines agency schedules befunolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00686mig. most nations, for tariff and trade purposes, schedule befunolol hydrochloride under hs 29329985 and sitc 51569. as of q4 2014, befunolol hydrochloride remains us fdas preferred term for this commodity. smiles: cc(c)ncc(coc1cccc2c1oc(c2)c(=o)c)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. betaxolol hydrochloride. this classification denotes a beta-adrenergic blocking agent and anti-glaucoma agent with the molecular formula c18h29no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6x97d2xt0o, chemically known as 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, hydrochloride, (+-)- but more generally known as betaxolol hydrochloride, which bears us nih compound identifier 107952. european medicines agency schedules betaxolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13062mig. most nations, for tariff and trade purposes, schedule betaxolol hydrochloride under hs 29221980. as of q4 2014, betaxolol hydrochloride remains us fdas preferred term for this commodity. betaxolol hydrochloride bears us nlm identifiers umls id c0699055 and nci concept code c47413. smiles: cc(c)ncc(coc1ccc(cc1)ccocc2cc2)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bevantolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c20h27no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4vb9hu07bc, chemically known as 2-propanol, 1-((3,4-dimethoxyphenethyl)amino)-3-(m-tolyloxy)-, monohydrochloride but more generally known as bevantolol hydrochloride, which bears us nih compound identifier 39324. european medicines agency schedules bevantolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00793mig. most nations, for tariff and trade purposes, schedule bevantolol hydrochloride under hs 29225000 and sitc 51467. as of q4 2014, bevantolol hydrochloride remains us fdas preferred term for this commodity. smiles: cc1cccc(c1)occ(cnccc2ccc(c(c2)oc)oc)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bisoprolol fumarate. this classification denotes a beta-adrenergic blocking agent with the molecular formula 2c18h31no4.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ur59kn573l, chemically known as 2-propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)- but more generally known as bisoprolol fumarate, which bears us nih compound identifier 2405. european medicines agency schedules bisoprolol fumarate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00832mig. most nations, for tariff and trade purposes, schedule bisoprolol fumarate under hs 29221980 and sitc 51461. as of q4 2014, bisoprolol fumarate remains us fdas preferred term for this commodity. bisoprolol fumarate bears us nlm identifiers umls id c0543473 and nci concept code c28871. smiles: cc(c)ncc(coc1ccc(cc1)coccoc(c)c)o.cc(c)ncc(coc1ccc(cc1)coccoc(c)c)o.c(=c/c(=o)o)\\c(=o)o.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bisoprolol hemifumarate. this classification denotes a beta-adrenergic blocking agent with the molecular formula 2c18h31no4.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ur59kn573l, chemically known as 2-propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (+/-)-, (e)-2-butenedioate (2:1) (salt), but more generally known as bisoprolol hemifumarate, which bears us nih compound identifier 2405. european medicines agency schedules bisoprolol hemifumarate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13096mig. most nations, for tariff purposes, schedule bisoprolol hemifumarate under hs 29221980. smiles: cc(c)ncc(coc1ccc(cc1)coccoc(c)c)o.cc(c)ncc(coc1ccc(cc1)coccoc(c)c)o.c(=c/c(=o)o)\\c(=o)o.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bisoprolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c18h31no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2ex58570np. most nations, for tariff and trade purposes, schedule bisoprolol hydrochloride under hs 29221980. as of q4 2014, bisoprolol hydrochloride remains us fdas preferred term for this commodity. smiles: cc(c)ncc(coc1ccc(cc1)coccoc(c)c)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bucindolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c22h25n3o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sh683g4qii, chemically known as 2-(2-hydroxy-3-((2-(3-indolyl)-1,1-dimethylethyl)amino)propoxy)benzonitrile hydrochloride but more generally known as bucindolol hydrochloride, which bears us nih compound identifier 51044. european medicines agency schedules bucindolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00886mig. most nations, for tariff and trade purposes, schedule bucindolol hydrochloride under hs 29339990 and sitc 51577. as of q4 2014, bucindolol hydrochloride remains us fdas preferred term for this commodity. smiles: cc(c)(cc1c[nh]c2c1cccc2)ncc(coc3ccccc3c#n)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bucumolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c17h23no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u2z7867qu7, chemically known as 5-methyl-8-(2-hydroxy-3-t-butylaminopropoxy)coumarin hydrochloride, dl- but more generally known as bucumolol hydrochloride, which bears us nih compound identifier 169786. european medicines agency schedules bucumolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21960. most nations, for tariff and trade purposes, schedule bucumolol hydrochloride under hs 29322985. as of q4 2014, bucumolol hydrochloride remains us fdas preferred term for this commodity. smiles: cc1ccc(c2c1ccc(=o)o2)occ(cnc(c)(c)c)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bunitrolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular structure c14h20n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, a42vus2x73 chemically known as 2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)benzonitrile, hydrochloride, but more commonly known as bunitrolol hydrochloride, which bears us nih compound identifier 31641. european medicines agency schedules bunitrolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00900mig. most nations, for tariff and trade purposes, schedule bunitrolol hydrochloride under hs 29269095 and sitc 51484. as of q4 2014, bunitrolol hydrochloride remains us fdas preferred term for this commodity. smiles: cc(c)(c)ncc(coc1ccccc1c#n)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. bupranolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c14h22clno2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dtc2g3gdpl, chemically known as 2-propanol, 1-tert-butylamino-3-(6-chloro-m-tolyloxy)-, hydrochloride but more generally known as bupranolol hydrochloride, which bears us nih compound identifier 27072. european medicines agency schedules bupranolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00903mig. most nations, for tariff and trade purposes, schedule bupranolol hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, bupranolol hydrochloride remains us fdas preferred term for this commodity. smiles: cc1ccc(c(c1)occ(cnc(c)(c)c)o)cl.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. carteolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c16h24n2o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4797w6i0t4, chemically known as 2(1h)-quinolinone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro- but more generally known as carteolol hydrochloride, which bears us nih compound identifier 2583. european medicines agency schedules carteolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13251mig. most nations, for tariff and trade purposes, schedule carteolol hydrochloride under hs 29337900 and sitc 51561. as of q4 2014, carteolol hydrochloride remains us fdas preferred term for this commodity. carteolol hydrochloride bears us nlm identifiers umls id c0543450 and nci concept code c28905. smiles: cc(c)(c)ncc(coc1cccc2c1ccc(=o)n2)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. celiprolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c20h33n3o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g1m3398594, chemically known as 3-(3-acetyl-4-(3-((tert-butyl)amino)-2-hydroxypropoxy)phenyl)-1,1-diethyluronium chloride but more generally known as celiprolol hydrochloride, which bears us nih compound identifier 42373. european medicines agency schedules celiprolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01146mig. most nations, for tariff and trade purposes, schedule celiprolol hydrochloride under hs 29242190 and sitc 51473. as of q4 2014, celiprolol hydrochloride remains us fdas preferred term for this commodity. celiprolol hydrochloride bears us nlm identifiers umls id c0700475 and nci concept code c81655. smiles: ccn(cc)c(=o)nc1ccc(c(c1)c(=o)c)occ(cnc(c)(c)c)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. cicloprolol hydrochloride. this classification denotes the hydrochloride form of a beta-adrenergic blocking agent with the molecular formula c18h29no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1k2ach4u3r, chemically known as 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethoxy)phenoxy)-3-((1-methylethyl)amino)- but more generally known as cicloprolol, which bears us nih compound identifier 146294. european medicines agency schedules cicloprolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06248mig. the term cicloprolol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 37, no. 6, 1983, list 23). cicloprolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cicloprolol hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, cicloprolol hydrochloride remains us fdas preferred term for this commodity. cicloprolol hydrochloride bears us nlm identifiers umls id c0074661 and nci concept code c90795. smiles: cc(c)ncc(coc1ccc(cc1)occocc2cc2)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. cloranolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c13h19cl2no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 79sq2wfq23, chemically known as (+/-)-dichlorophenoxy)-3-tert-butylamino-2-propanol hydrochloride, but more generally known as cloranolol hydrochloride, which bears us nih compound identifier 162743. european medicines agency schedules cloranolol hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06752mig. most nations, for tariff purposes, schedule cloranolol hydrochloride under hs 29221980. smiles: cc(c)(c)ncc(coc1cc(ccc1cl)cl)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. esmolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c16h25no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v05260lc8d, chemically known as benzenepropanoic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, methyl ester but more generally known as esmolol hydrochloride, which bears us nih compound identifier 59768. european medicines agency schedules esmolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01959mig. most nations, for tariff and trade purposes, schedule esmolol hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, esmolol hydrochloride remains us fdas preferred term for this commodity. esmolol hydrochloride bears us nlm identifiers umls id c0700606 and nci concept code c47519. smiles: cc(c)ncc(coc1ccc(cc1)ccc(=o)oc)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. flestolol sulfate. this classification denotes a beta-adrenergic blocking agent with the molecular formula c15h22fn3o4.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t5mwt8445u, chemically known as o-fluorobenzoic acid, 3-ester with (+-)-(2-((2,3-dihydroxypropyl)amino)-2-methylpropyl)urea, sulfate (1:1) (salt) but more generally known as flestolol sulfate, which bears us nih compound identifier 55884. most nations, for tariff and trade purposes, schedule flestolol sulfate under hs 29242190 and sitc 51473. as of q4 2014, flestolol sulfate remains us fdas preferred term for this commodity. flestolol sulfate bears us nlm identifiers umls id c0956983 and nci concept code c73017. smiles: cc(c)(cnc(=o)n)ncc(coc(=o)c1ccccc1f)o.os(=o)(=o)o.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. levobetaxolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c18h29no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8mr4w4o06j, chemically known as 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, hydrochloride, (2s)- but more generally known as levobetaxolol hydrochloride, which bears us nih compound identifier 60656. most nations, for tariff and trade purposes, schedule levobetaxolol hydrochloride under hs 29221980. as of q4 2014, levobetaxolol hydrochloride remains us fdas preferred term for this commodity. levobetaxolol hydrochloride bears us nlm identifiers umls id c0876234 and nci concept code c66007. smiles: cc(c)nc[c@@h](coc1ccc(cc1)ccocc2cc2)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. levobunolol hydrochloride. this classification denotes a beta-adrenergic blocking agent and anti-glaucoma agent with the molecular formula c17h25no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o90s49ldhh, chemically known as 1(2h)-naphthalenone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, hydrochloride, (-)- but more generally known as levobunolol hydrochloride, which bears us nih compound identifier 34060. european medicines agency schedules levobunolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14351mig. most nations, for tariff and trade purposes, schedule levobunolol hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, levobunolol hydrochloride remains us fdas preferred term for this commodity. levobunolol hydrochloride bears us nlm identifiers umls id c0591174 and nci concept code c29153. smiles: cc(c)(c)nc[c@@h](coc1cccc2c1cccc2=o)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. metipranolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c17h27no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fbw237alkd, chemically known as 4-(2-hydroxy-3-((1-methylethyl)-amino)propoxy)-2,3,6-trimethylphenol 1-acetate but more generally known as metipranolol hydrochloride, which bears us nih compound identifier 31477. european medicines agency schedules metipranolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03267mig. most nations, for tariff and trade purposes, schedule metipranolol hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, metipranolol hydrochloride remains us fdas preferred term for this commodity. metipranolol hydrochloride bears us nlm identifiers umls id c0982282 and nci concept code c77946. smiles: cc1cc(c(c(c1oc(=o)c)c)c)occ(cnc(c)c)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. metoprolol fumarate. this classification denotes a beta-adrenergic blocking agent 2c15h25no3.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier io1c09z674, chemically known as 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+/-)-, (e)-2-butanedioate (2:1) (salt), but more generally known as metoprolol fumarate, which bears us nih compound identifier 6446646. european medicines agency schedules metoprolol fumarate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03273mig. most nations, for tariff and trade purposes, schedule metoprolol fumarate under hs 29221980 and sitc 51461. as of q4 2014, metoprolol fumarate remains us fdas preferred term for this commodity. metoprolol fumarate bears us nlm identifiers umls id c0350132 and nci concept code c66133. smiles: cc(c)ncc(coc1ccc(cc1)ccoc)o.cc(c)ncc(coc1ccc(cc1)ccoc)o.c(=c/c(=o)o)\\c(=o)o.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. metoprolol succinate. this classification denotes a beta-adrenergic blocking agent with the molecular formula 2c15h25no3.c4h6o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier th25pd4ccb, chemically known as 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, butanedioate (2:1) (salt) but more generally known as metoprolol succinate, which bears us nih compound identifier 62937. european medicines agency schedules metoprolol succinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03274mig. most nations, for tariff and trade purposes, schedule metoprolol succinate under hs 29221980 and sitc 51461. as of q4 2014, metoprolol succinate remains us fdas preferred term for this commodity. metoprolol succinate bears us nlm identifiers umls id c0724633 and nci concept code c29254. smiles: cc(c)ncc(coc1ccc(cc1)ccoc)o.cc(c)ncc(coc1ccc(cc1)ccoc)o.c(cc(=o)o)c(=o)o.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. metoprolol tartrate. this classification denotes a beta-adrenergic blocking agent with the molecular formula 2c15h25no3.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w5s57y3a5l, chemically known as 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)- but more generally known as metoprolol tartrate, which bears us nih compound identifier 4171. european medicines agency schedules metoprolol tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03275mig. most nations, for tariff and trade purposes, schedule metoprolol tartrate under hs 29221980 and sitc 51461. as of q4 2014, metoprolol tartrate remains us fdas preferred term for this commodity. metoprolol tartrate bears us nlm identifiers umls id c0700776 and nci concept code c29255. smiles: cc(c)ncc(coc1ccc(cc1)ccoc)o.cc(c)ncc(coc1ccc(cc1)ccoc)o.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. oxprenolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c15h23no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f4xsi7sniu, chemically known as 2-propanol, 1-(o-allyloxyphenoxy)-3-isopropylamino-, hydrochloride but more generally known as oxprenolol hydrochloride, which bears us nih compound identifier 71172. european medicines agency schedules oxprenolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03578mig. most nations, for tariff and trade purposes, schedule oxprenolol hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, oxprenolol hydrochloride remains us fdas preferred term for this commodity. oxprenolol hydrochloride bears us nlm identifiers umls id c0700460 and nci concept code c66277. smiles: cc(c)ncc(coc1ccccc1occ=c)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. penbutolol sulfate. this classification denotes a beta-adrenergic blocking agent and antiarrhythmic agent with the molecular formula 2c18h29no2.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier us71433228, chemically known as 2-propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (s)-, sulfate (2:1) (salt) but more generally known as penbutolol sulfate, which bears us nih compound identifier 38010. european medicines agency schedules penbutolol sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03673mig. most nations, for tariff and trade purposes, schedule penbutolol sulfate under hs 29221980 and sitc 51461. as of q4 2014, penbutolol sulfate remains us fdas preferred term for this commodity. penbutolol sulfate bears us nlm identifiers umls id c0282292 and nci concept code c61882. smiles: cc(c)(c)nc[c@@h](coc1ccccc1c2cccc2)o.cc(c)(c)nc[c@@h](coc1ccccc1c2cccc2)o.os(=o)(=o)o.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. tertatolol hydrochloride. this classification denotes a beta-adrenergic blocking agent c16h25no2s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9sdh60z1no, chemically known as 2-propanol, 1-((3,4-dihydro-2h-1-benzothiopyran-8-yl)oxy)-3-((1,1-dimethylethyl)amino)-, hydrochloride (1:1), but more generally known as tertatolol hydrochloride, which bears us nih compound identifier 161777. european medicines agency schedules tertatolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32680. most nations, for tariff and trade purposes, schedule tertatolol hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, tertatolol hydrochloride remains us fdas preferred term for this commodity. smiles: cc(c)(c)ncc(coc1cccc2c1sccc2)o.cl.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. timolol anhydrous. this classification denotes a beta-adrenergic blocking agent with the molecular formula c13h24n4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5jky92s7br. the term timolol anhydrous is an international non-proprietary name or inn. most nations, for tariff and trade purposes, schedule timolol anhydrous under hs 29349990. as of q4 2014, timolol anhydrous remains us fdas preferred term for this commodity. timolol anhydrous bears us nlm identifiers umls id c2983887 and nci concept code c90802. smiles: cc(c)(c)nc[c@@h](coc1c(nsn1)n2ccocc2)o.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. timolol hemihydrate. this classification denotes a beta-adrenergic blocking agent with the molecular formula 2c13h24n4o3s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 817w3c6175, chemically known as (s)-1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-2-propanol hemihydrate, but more generally known as timolol hemihydrate, which bears us nih compound identifier 62933. european medicines agency schedules timolol hemihydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11069mig. most nations, for tariff purposes, schedule timolol hemihydrate under hs 29349990. smiles: cc(c)(c)nc[c@@h](coc1c(nsn1)n2ccocc2)o.cc(c)(c)nc[c@@h](coc1c(nsn1)n2ccocc2)o.o.. "
"adrenergic blocking agent propanolamines. this classification denotes adrenergic blocking agents made from amino alcohols containing the propanolamine (nh2ch2chohch2) group and its derivatives.. timolol maleate. this classification denotes a beta-adrenergic blocking agent with the molecular formula c13h24n4o3s.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p8y54f701r, chemically known as 2-propanol, 1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-, (-)-, maleate (1:1) (salt) but more generally known as timolol maleate, which bears us nih compound identifier 5281056. european medicines agency schedules timolol maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04875mig. most nations, for tariff and trade purposes, schedule timolol maleate under hs 29349990 and sitc 51579. as of q4 2014, timolol maleate remains us fdas preferred term for this commodity. timolol maleate bears us nlm identifiers umls id c0087093 and nci concept code c29501. smiles: cc(c)(c)nc[c@@h](coc1c(nsn1)n2ccocc2)o.c(=c\\c(=o)o)\\c(=o)o.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. . "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. nafetolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c19h29no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mal2xf17mp, chemically known as 1,4-ethanonaphthalen-5-ol, 8-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-, but generally known as nafetolol, which bears us nih compound identifier 68668. european medicines agency schedules nafetolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09121mig. the term nafetolol is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). nafetolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nafetolol under hs 29221980 and sitc 51461. as of q4 2014, nafetolol remains the us fda preferred term for this commodity. nafetolol bears us nlm identifiers umls id c2983886 and nci concept code c90799. smiles: o(c1c2c3ccc(cc3)c2c(o)cc1)cc(o)cnc(c)(c)c.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. butamoxane. this classification denotes an adrenergic antagonist with the molecular formula c13h19no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7725983gsd, chemically known as 1,4-benzodioxan-2-methylamine, n-butyl- but generally known as butamoxane, which bears us nih compound identifier 20504. european medicines agency schedules butamoxane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06002mig. the term butamoxane is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). butamoxane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule butamoxane under hs 29329985 and sitc 51569. as of q4 2014, butamoxane remains the us fda preferred term for this commodity. butamoxane bears us nlm identifiers umls id c0606819 and nci concept code c74104. smiles: o1c(cncccc)coc2c1cccc2.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. butidrine. this classification denotes an adrenergic antagonist with the molecular formula c16h25no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n2s0pkp5l5, chemically known as 5,6,7,8-tetrahydro-alpha-(((1-methylpropyl)amino)methyl)-2-naphthalenemethanol hydrochloride but generally known as butidrine, which bears us nih compound identifier 15176. butidrine most often comes in base and hydrochloride forms. european medicines agency schedules butidrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06016mig. the term butidrine is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). butidrine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule butidrine under hs 29221980 and sitc 51461. as of q4 2014, butidrine remains the us fda preferred term for this commodity. butidrine bears us nlm identifiers umls id c2698577 and nci concept code c79710. smiles: cl.oc(c[nh2]c(cc)c)c1cc2ccccc2cc1.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. butocrolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c19h23no6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f63sy70kv0, chemically known as 9-(3-(tert-butylamino)-2-hydroxypropoxyl)-4-hydroxy-7-methyl-5h-furo(3,2-g)(1)benzopyran-5-one. but generally known as butocrolol, which bears us nih compound identifier 189906. european medicines agency schedules butocrolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06027mig. the term butocrolol is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). butocrolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule butocrolol under hs 29329985 and sitc 51569. as of q4 2014, butocrolol remains the us fda preferred term for this commodity. butocrolol bears us nlm identifiers umls id c2698579 and nci concept code c77939. smiles: o(cc(o)cnc(c)(c)c)c1c2oc(cc(=o)c2c(o)c2c1occ2)c.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. carpindolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w8f97xp38w. european medicines agency schedules carpindolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06141mig. carpindolol generally arises in the molecular formula c19h28n2o4. the term carpindolol is an international non-proprietary name or inn. carpindolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carpindolol under hs 29339990 and sitc 51577. as of q4 2014, carpindolol remains the us fda preferred term for this commodity. carpindolol bears us nlm identifiers umls id c2699124 and nci concept code c76020. smiles: o(cc(o)cnc(c)(c)c)c1c2c([nh]c(c2)c(=o)oc(c)c)ccc1.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. dioxadilol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c16h25no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g25z4785lv, chemically known as (- )-1-(1,4-benzodioxan-2-ylmethoxy)-3-(tert-butylamino)-2-propanol. but generally known as dioxadilol, which bears us nih compound identifier 208844. european medicines agency schedules dioxadilol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07199mig. the term dioxadilol is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). dioxadilol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dioxadilol under hs 29329985 and sitc 51569. as of q4 2014, dioxadilol remains the us fda preferred term for this commodity. dioxadilol bears us nlm identifiers umls id c1880338 and nci concept code c65414. smiles: o(cc(o)cnc(c)(c)c)cc1oc2c(oc1)cccc2.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. ecastolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c26h33n3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier eeb95ds30p, chemically known as (- )-4-(3-((3,4-dimethoxy-phenethyl)amino)-2-hydroxypropoxy)-3-(5-isoxazolyl)butyranilide. but generally known as ecastolol, which bears us nih compound identifier 208905. european medicines agency schedules ecastolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06444mig. the term ecastolol is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). ecastolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ecastolol under hs 29349990 and sitc 51579. as of q4 2014, ecastolol remains the us fda preferred term for this commodity. ecastolol bears us nlm identifiers umls id c2348372 and nci concept code c72608. smiles: o(cc(o)cnccc1cc(oc)c(oc)cc1)c1c(cc(nc(=o)ccc)cc1)c1oncc1.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. ericolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 38r2p4piei. european medicines agency schedules ericolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06599mig. ericolol generally arises in the molecular formula c18h24clno3. the term ericolol is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24.) ericolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ericolol under hs 29221980 and sitc 51461. as of q4 2014, ericolol remains the us fda preferred term for this commodity. ericolol bears us nlm identifiers umls id c1880546 and nci concept code c65527. smiles: clc1cc(occ(o)cnc(c)(c)c)c(c2=cc(=o)cc2)cc1.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. idralfidine. this classification denotes an alpha-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e2u4w02tmr. european medicines agency schedules idralfidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08118mig. idralfidine generally arises in the molecular formula c11h14n4o. the term idralfidine is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26.) idralfidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule idralfidine under hs 29332990 and sitc 51573. as of q4 2014, idralfidine remains the us fda preferred term for this commodity. idralfidine bears us nlm identifiers umls id c2827191 and nci concept code c83779. smiles: cc\\1=cc(=o)c=c/c1=c\\nnc2=nccn2.cl.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. penirolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bt9y6d2dr0. european medicines agency schedules penirolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09670mig. penirolol generally arises in the molecular formula c15h22n2o2. the term penirolol is an international non-proprietary name or inn. penirolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule penirolol under hs 29269095 and sitc 51484. as of q4 2014, penirolol remains the us fda preferred term for this commodity. penirolol bears us nlm identifiers umls id c1882314 and nci concept code c66339. smiles: oc(cnc(cc)(c)c)coc1c(cccc1)c#n.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. quinazosin. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c17h23n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 436xk6qfmr, chemically known as 4-quinazolinamine, 6,7-dimethoxy-2-(4-(2-propenyl)-1-piperazinyl)- but generally known as quinazosin, which bears us nih compound identifier 27486. european medicines agency schedules quinazosin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10203mig. the term quinazosin is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). quinazosin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule quinazosin under hs 29335995 and sitc 51576. as of q4 2014, quinazosin remains the us fda preferred term for this commodity. quinazosin bears us nlm identifiers umls id c2347736 and nci concept code c72924. smiles: o(c1cc2nc(n3ccn(cc3)cc=c)nc(n)c2cc1oc)c.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. tolboxane. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c14h21bo2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 33p8jv23l7, chemically known as 1,3,2-dioxaborinane, 5-methyl-5-propyl-2-p-tolyl- but generally known as tolboxane, which bears us nih compound identifier 72134. european medicines agency schedules tolboxane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11149mig. the term tolboxane is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). tolboxane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, tolboxane remains the us fda preferred term for this commodity. tolboxane bears us nlm identifiers umls id c2699961 and nci concept code c75058. smiles: o1cc(ccc)(co[b]1c1ccc(cc1)c)c.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. tribendilol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k0744q5alp. european medicines agency schedules tribendilol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11259mig. tribendilol generally arises in the molecular formula c18h22n4o4. the term tribendilol is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26.) tribendilol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tribendilol under hs 29339990 and sitc 51577. as of q4 2014, tribendilol remains the us fda preferred term for this commodity. tribendilol bears us nlm identifiers umls id c2700071 and nci concept code c76561. smiles: o(cc(o)cnccoc1c(oc)cccc1)c1c2n[nh]nc2ccc1.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. trigevolol. this classification denotes a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l2d8de8s32. european medicines agency schedules trigevolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11294mig. trigevolol generally arises in the molecular formula c21h28n2o7. the term trigevolol is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27.) trigevolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule trigevolol under hs 29242995 and sitc 51479. as of q4 2014, trigevolol remains the us fda preferred term for this commodity. trigevolol bears us nlm identifiers umls id c2825714 and nci concept code c81657. smiles: o(cc(o)cnccoc1cc(c(o)cc1)c(=o)n)c1ccc(occoc)cc1.. "
"adrenergic blocking agents, synthesized. this classification denotes adrenergic blocking agents composed of multiple constituents, with no dominant constituent.. trigevolol mesilate or mesylate. this classification denotes the mesylate form of a beta-adrenergic blocking agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l2d8de8s32. european medicines agency schedules trigevolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11294mig. trigevolol generally arises in the molecular formula c21h28n2o7. the term trigevolol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 1, no. 4, 1987, list 27.) trigevolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule trigevolol mesylate under hs 29242995. as of q4 2014, trigevolol mesylate remains us fdas preferred term for this commodity. smiles: coccoc1ccc(cc1)occ(cnccoc2ccc(c(c2)c(=o)n)o)o.cs(=o)(=o)o.. "
"adrenergic blocking agent pyrimidine nucleosides and quaternary ammonium compounds and secologanin tryptamine alkaloids and spiro compounds and sulfonamides. this classification denotes adrenergic blocking agent drugs made from or based in part on pyrimidine nucleosides, quaternary ammonium compounds, secologanin tryptamine alkaloids, spiro compounds, or sulfonamides. . "
"adrenergic blocking agent pyrimidine nucleosides and quaternary ammonium compounds and secologanin tryptamine alkaloids and spiro compounds and sulfonamides. this classification denotes adrenergic blocking agent drugs made from or based in part on pyrimidine nucleosides, quaternary ammonium compounds, secologanin tryptamine alkaloids, spiro compounds, or sulfonamides. yohimbine. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c21h26n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2y49vwd90q, chemically known as 20.alpha.-yohimban-16.beta.-carboxylic acid, 17.alpha.-hydroxy-, methyl ester, monohydrochloride but generally known as yohimbine, which bears us nih compound identifier 2866. european medicines agency schedules yohimbine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15744mig. world health organization schedules yohimbine in its anatomical therapeutic chemical (atc) classification. most nations schedule yohimbine under hs 29399990 and sitc 54149. as of q4 2014, yohimbine remains the us fda preferred term for this commodity. yohimbine bears us nlm identifiers umls id c0724441 and nci concept code c77304. smiles: oc1c(c2c(cn3c(c2)c2[nh]c4c(c2cc3)cccc4)cc1)c(=o)oc.. "
"adrenergic blocking agent pyrimidine nucleosides and quaternary ammonium compounds and secologanin tryptamine alkaloids and spiro compounds and sulfonamides. this classification denotes adrenergic blocking agent drugs made from or based in part on pyrimidine nucleosides, quaternary ammonium compounds, secologanin tryptamine alkaloids, spiro compounds, or sulfonamides. tamsulosin. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c20h28n2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g3p28oml5i, chemically known as benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-, (r)- but generally known as tamsulosin, which bears us nih compound identifier 129211. european medicines agency schedules tamsulosin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10827mig. the term tamsulosin is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules tamsulosin in its anatomical therapeutic chemical (atc) classification. tamsulosin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tamsulosin under hs 29350090 and sitc 51580. as of q4 2014, tamsulosin remains the us fda preferred term for this commodity. tamsulosin bears us nlm identifiers umls id c0257343 and nci concept code c75055. smiles: s(=o)(=o)(n)c1cc(cc(nccoc2c(occ)cccc2)c)ccc1oc.. "
"adrenergic blocking agent pyrimidine nucleosides and quaternary ammonium compounds and secologanin tryptamine alkaloids and spiro compounds and sulfonamides. this classification denotes adrenergic blocking agent drugs made from or based in part on pyrimidine nucleosides, quaternary ammonium compounds, secologanin tryptamine alkaloids, spiro compounds, or sulfonamides. spirendolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c21h31no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 96789094br, chemically known as spiro(cyclohexane-1,2-(2h)inden)-1(3h)-one, 4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-, (+-)- but generally known as spirendolol, which bears us nih compound identifier 68857. european medicines agency schedules spirendolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10623mig. the term spirendolol is an international non-proprietary name. spirendolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule spirendolol under hs 29221980 and sitc 51461. as of q4 2014, spirendolol remains the us fda preferred term for this commodity. spirendolol bears us nlm identifiers umls id c0629350 and nci concept code c66562. smiles: o=c1c2(ccccc2)cc2c1cccc2occ(o)cnc(c)(c)c.. "
"adrenergic blocking agent pyrimidine nucleosides and quaternary ammonium compounds and secologanin tryptamine alkaloids and spiro compounds and sulfonamides. this classification denotes adrenergic blocking agent drugs made from or based in part on pyrimidine nucleosides, quaternary ammonium compounds, secologanin tryptamine alkaloids, spiro compounds, or sulfonamides. bretylium. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c11h17brn, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rzr75eq2kj, chemically known as benzenemethanaminium, 2-bromo-n-ethyl-n,n-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1) but generally known as bretylium, which bears us nih compound identifier 2431. bretylium most often comes in base, bromide, p-toluenesulfonate, and tosylate forms. european medicines agency schedules bretylium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00867mig. bretylium is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, bretylium remains the us fda preferred term for this commodity. bretylium bears us nlm identifiers umls id c0054040 and nci concept code c77300. smiles: cc[n+](c)(c)cc1=cc=cc=c1br.. "
"adrenergic blocking agent pyrimidine nucleosides and quaternary ammonium compounds and secologanin tryptamine alkaloids and spiro compounds and sulfonamides. this classification denotes adrenergic blocking agent drugs made from or based in part on pyrimidine nucleosides, quaternary ammonium compounds, secologanin tryptamine alkaloids, spiro compounds, or sulfonamides. bretylium tosilate. this classification denotes an antiarrhythmic agent with the molecular formula c11h17brn.c7h7o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 78zp3yr353, chemically known as 2-bromo-n-ethyl-n,n-dimethylbenzenemethanaminium 4-methylbenzenesulfonate but more generally known as bretylium tosilate, which bears us nih compound identifier 6100. european medicines agency schedules bretylium tosilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05887mig. the term bretylium tosylate is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules bretylium tosilate in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule bretylium tosilate under hs 29239000 and sitc 51481. smiles: cc[n+](c)(c)cc1ccccc1br.cc1ccc(cc1)s(=o)(=o)[o-].. "
"adrenergic blocking agent pyrimidine nucleosides and quaternary ammonium compounds and secologanin tryptamine alkaloids and spiro compounds and sulfonamides. this classification denotes adrenergic blocking agent drugs made from or based in part on pyrimidine nucleosides, quaternary ammonium compounds, secologanin tryptamine alkaloids, spiro compounds, or sulfonamides. tamsulosin hydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c20h28n2o5s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 11sv1951mr, chemically known as benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-, monohydrochloride, (r)- but more generally known as tamsulosin hydrochloride, which bears us nih compound identifier 5362376. european medicines agency schedules tamsulosin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04673mig. most nations, for tariff and trade purposes, schedule tamsulosin hydrochloride under hs 29350090 and sitc 51580. as of q4 2014, tamsulosin hydrochloride remains us fdas preferred term for this commodity. tamsulosin hydrochloride bears us nlm identifiers umls id c0771774 and nci concept code c29486. smiles: ccoc1ccccc1occn[c@h](c)cc2ccc(c(c2)s(=o)(=o)n)oc.cl.. "
"adrenergic blocking agent pyrimidine nucleosides and quaternary ammonium compounds and secologanin tryptamine alkaloids and spiro compounds and sulfonamides. this classification denotes adrenergic blocking agent drugs made from or based in part on pyrimidine nucleosides, quaternary ammonium compounds, secologanin tryptamine alkaloids, spiro compounds, or sulfonamides. yohimbine hydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c21h26n2o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nb2e1yp49f, chemically known as 20.alpha.-yohimban-16.beta.-carboxylic acid, 17.alpha.-hydroxy-, methyl ester, monohydrochloride but more generally known as yohimbine hydrochloride, which bears us nih compound identifier 2866. european medicines agency schedules yohimbine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15745mig. most nations, for tariff and trade purposes, schedule yohimbine hydrochloride under hs 29399990 and sitc 54149. as of q4 2014, yohimbine hydrochloride remains us fdas preferred term for this commodity. yohimbine hydrochloride bears us nlm identifiers umls id c0521933 and nci concept code c75062. smiles: coc(=o)[c@h]1[c@h](cc[c@@h]2[c@@h]1c[c@h]3c4c(c5ccccc5[nh]4)ccn3c2)o.cl.. "
"adrenergic blocking agent phenethylamines and quinolines. this classification denotes adrenergic blocking agent drugs made from or based in part on phenethylamines, or quinolines. . "
"adrenergic blocking agent phenethylamines and quinolines. this classification denotes adrenergic blocking agent drugs made from or based in part on phenethylamines, or quinolines. hexoprenaline. this classification denotes an adrenergic beta-2 receptor agonist, bronchodilator agent, and tocolytic agent with the molecular formula c22h32n2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g9l6b3w684, chemically known as 1,12-bis(3,4-dihydroxyphenyl)-3,10-diaza-1,12-dodecandiol but generally known as hexoprenaline, which bears us nih compound identifier 3609. european medicines agency schedules hexoprenaline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08041mig. world health organization schedules hexoprenaline in its anatomical therapeutic chemical (atc) classification. hexoprenaline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule hexoprenaline under hs 29225000 and sitc 51467. as of q4 2014, hexoprenaline remains the us fda preferred term for this commodity. smiles: oc(cnccccccncc(o)c1cc(o)c(o)cc1)c1cc(o)c(o)cc1.. "
"adrenergic blocking agent phenethylamines and quinolines. this classification denotes adrenergic blocking agent drugs made from or based in part on phenethylamines, or quinolines. brefonalol. this classification denotes a vasodilating agent and adrenergic antagonist with the molecular formula c22h28n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dvo6ssg9s3, chemically known as (+-)-6-(2-((1,1-dimethyl-3-phenylpropyl)amino)-1-hydroxyethyl)-3,4-dihydrocarbostyril but generally known as brefonalol, which bears us nih compound identifier 65880. european medicines agency schedules brefonalol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05883mig. the term brefonalol is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). brefonalol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule brefonalol under hs 29337900 and sitc 51561. as of q4 2014, brefonalol remains the us fda preferred term for this commodity. brefonalol bears us nlm identifiers umls id c2347204 and nci concept code c72653. smiles: oc(cnc(ccc1ccccc1)(c)c)c1cc2ccc(=o)nc2cc1.. "
"adrenergic blocking agent phenethylamines and quinolines. this classification denotes adrenergic blocking agent drugs made from or based in part on phenethylamines, or quinolines. hexoprenaline dihydrochloride. this classification denotes an adrenergic beta-2 receptor agonist, bronchodilator agent, and tocolytic agent with the molecular formula c22h32n2o6.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 97tdi0239i, chemically known as benzyl alcohol, .alpha.,.alpha.-(hexamethylenebis(iminomethylene))bis(3,4-dihydroxy-, dihydrochloride, but more generally known as hexoprenaline dihydrochloride, which bears us nih compound identifier 20321. european medicines agency schedules hexoprenaline dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08041mig. most nations, for tariff purposes, schedule hexoprenaline dihydrochloride under hs 29225000. smiles: c1cc(c(cc1c(cnccccccncc(c2ccc(c(c2)o)o)o)o)o)o.cl.cl.. "
"adrenergic blocking agent phenethylamines and quinolines. this classification denotes adrenergic blocking agent drugs made from or based in part on phenethylamines, or quinolines. hexoprenaline sulfate. this classification denotes a beta-adrenergic agonist with the molecular formula c22h32n2o6.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u851s9102c, chemically known as 4,4-(hexane-1,6-diylbis(iminio(1-hydroxyethylene)))dipyrocatecholsulphate but more generally known as hexoprenaline sulfate, which bears us nih compound identifier 36094. european medicines agency schedules hexoprenaline sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02516mig. most nations, for tariff and trade purposes, schedule hexoprenaline sulfate under hs 29225000 and sitc 51467. as of q4 2014, hexoprenaline sulfate remains us fdas preferred term for this commodity. hexoprenaline sulfate bears us nlm identifiers umls id c0813200 and nci concept code c83756. smiles: c1cc(c(cc1c(cnccccccncc(c2ccc(c(c2)o)o)o)o)o)o.os(=o)(=o)o.. "
"adrenergic blocking agent quinazolines. this classification denotes adrenergic blocking agents made from benzopyrimidines, or compounds consisting of two six-membered rings, one benzene, one pyrimidine ring.. . "
"adrenergic blocking agent quinazolines. this classification denotes adrenergic blocking agents made from benzopyrimidines, or compounds consisting of two six-membered rings, one benzene, one pyrimidine ring.. alfuzosin. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c19h27n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 90347ytw5f, chemically known as 2-furancarboxamide, n-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro- but generally known as alfuzosin, which bears us nih compound identifier 2092. alfuzosin comes in base and hydrochloride forms. european medicines agency schedules alfuzosin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05319mig. the term alfuzosin is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules alfuzosin in its anatomical therapeutic chemical (atc) classification. alfuzosin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule alfuzosin under hs 29349990 and sitc 51579. as of q4 2014, alfuzosin remains the us fda preferred term for this commodity. alfuzosin bears us nlm identifiers umls id c0051150 and nci concept code c61627. smiles: o1c(ccc1)c(=o)ncccn(c1nc2c(c(n1)n)cc(oc)c(oc)c2)c.. "
"adrenergic blocking agent quinazolines. this classification denotes adrenergic blocking agents made from benzopyrimidines, or compounds consisting of two six-membered rings, one benzene, one pyrimidine ring.. doxazosin. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c23h25n5o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nw1291f1w8, chemically known as 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin but generally known as doxazosin, which bears us nih compound identifier 3157. european medicines agency schedules doxazosin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06384mig. the term doxazosin is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules doxazosin in its anatomical therapeutic chemical (atc) classification. doxazosin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule doxazosin under hs 29349990 and sitc 51579. as of q4 2014, doxazosin remains the us fda preferred term for this commodity. doxazosin bears us nlm identifiers umls id c0114873 and nci concept code c61737. smiles: o1c(c(=o)n2ccn(cc2)c2nc3c(c(n2)n)cc(oc)c(oc)c3)coc2c1cccc2.. "
"adrenergic blocking agent quinazolines. this classification denotes adrenergic blocking agents made from benzopyrimidines, or compounds consisting of two six-membered rings, one benzene, one pyrimidine ring.. alfuzosin hydrochloride. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c19h27n5o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 75046a1xtn, chemically known as 2-furancarboxamide, n-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-, monohydrochloride (+-)- but more generally known as alfuzosin hydrochloride, which bears us nih compound identifier 71764. the base coompound, alfuzosin, also comes in simple form. european medicines agency schedules alfuzosin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00340mig. most nations, for tariff and trade purposes, schedule alfuzosin hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, alfuzosin hydrochloride remains us fdas preferred term for this commodity. alfuzosin hydrochloride bears us nlm identifiers umls id c0102130 and nci concept code c53408. smiles: cn(cccnc(=o)c1ccco1)c2nc3cc(c(cc3c(n2)n)oc)oc.cl.. "
"adrenergic blocking agent quinazolines. this classification denotes adrenergic blocking agents made from benzopyrimidines, or compounds consisting of two six-membered rings, one benzene, one pyrimidine ring.. doxazosin mesilate or mesylate. this classification denotes an alpha-adrenergic blocking agent with the molecular formula c23h25n5o5.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 86p6pqk0mu, chemically known as piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)-, monomethanesulfonate, but more generally known as doxazosin mesylate, which bears us nih compound identifier 3157. european medicines agency schedules doxazosin mesylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06384mig. most nations, for tariff purposes, schedule doxazosin mesylate under hs 29349990. as of q4 2014, doxazosin mesylate remains us fdas preferred term for this commodity. doxazosin mesylate bears us nlm identifiers umls id c0678136 and nci concept code c29005. smiles: coc1cc2c(cc1oc)nc(nc2n)n3ccn(cc3)c(=o)c4coc5ccccc5o4.cs(=o)(=o)o.. "
"adrenergic blocking agent isoquinolines. this classification denotes adrenergic blocking agents based on a group of compounds with the heterocyclic ring structure of benzo(c)pyridine.. . "
"adrenergic blocking agent isoquinolines. this classification denotes adrenergic blocking agents based on a group of compounds with the heterocyclic ring structure of benzo(c)pyridine.. adaprolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c26h39no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xp9911i1wl, chemically known as (+/-)-2-(1-adamantyl)ethyl (p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)acetate, but generally known as adaprolol, which bears us nih compound identifier 60732. european medicines agency schedules adaprolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05262mig. most nations schedule adaprolol under hs 29221980 and sitc 51461. as of q4 2014, adaprolol remains the us fda preferred term for this commodity. adaprolol bears us nlm identifiers umls id c0645354 and nci concept code c77938. smiles: cc(c)ncc(coc1=cc=c(c=c1)cc(=o)occc23cc4cc(c2)cc(c4)c3)o.. "
"adrenergic blocking agent isoquinolines. this classification denotes adrenergic blocking agents based on a group of compounds with the heterocyclic ring structure of benzo(c)pyridine.. debrisoquin sulfate. this classification denotes an alpha-adrenergic blocking agent with the molecular formula 2c10h13n3.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q94064n9nw, chemically known as 1,2,3, 4-tetrahydro-isoquinoline-2-carboxamidine sulfate but generally known as debrisoquin sulfate, which bears us nih compound identifier 2966. european medicines agency schedules debrisoquine sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01567mig. as of q4 2014, debrisoquin sulfate remains the us fda preferred term for this commodity. debrisoquin sulfate bears us nlm identifiers umls id c0700449 and nci concept code c77302. smiles: c1cn(cc2=cc=cc=c21)c(=n)n.c1cn(cc2=cc=cc=c21)c(=n)n.os(=o)(=o)o.. "
"adrenergic blocking agent isoquinolines. this classification denotes adrenergic blocking agents based on a group of compounds with the heterocyclic ring structure of benzo(c)pyridine.. tilisolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c17h24n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier quf41mf56g, chemically known as 1(2h)-isoquinolinone, 4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-2-methyl- but generally known as tilisolol, which bears us nih compound identifier 5474. european medicines agency schedules tilisolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11053mig. the term tilisolol is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). tilisolol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tilisolol under hs 29337900 and sitc 51561. as of q4 2014, tilisolol remains the us fda preferred term for this commodity. tilisolol bears us nlm identifiers umls id c0076678 and nci concept code c76560. smiles: o(cc(o)cnc(c)(c)c)c1c2c(c(=o)n(c1)c)cccc2.. "
"adrenergic blocking agent isoquinolines. this classification denotes adrenergic blocking agents based on a group of compounds with the heterocyclic ring structure of benzo(c)pyridine.. adaprolol maleate. this classification denotes a beta-adrenergic blocking agent with the molecular formula c26h39no4.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2i8rv6wl9a, chemically known as benzeneacetic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, 2-tricyclo(3.3.1.1(sup 3,7))dec-1-ylethyl ester, (+-)-, (z)-2-butenedioate (1:1) (salt) but more generally known as adaprolol maleate, which bears us nih compound identifier 6435805. most nations, for tariff and trade purposes, schedule adaprolol maleate under hs 29221980 and sitc 51461. as of q4 2014, adaprolol maleate remains us fdas preferred term for this commodity. adaprolol maleate bears us nlm identifiers umls id c0645353 and nci concept code c79960. smiles: cc(c)ncc(coc1ccc(cc1)cc(=o)occc23cc4cc(c2)cc(c4)c3)o.c(=c\\c(=o)o)\\c(=o)o.. "
"adrenergic blocking agent isoquinolines. this classification denotes adrenergic blocking agents based on a group of compounds with the heterocyclic ring structure of benzo(c)pyridine.. tilisolol hydrochloride. this classification denotes a beta-adrenergic blocking agent c17h24n2o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jw02t8utin, chemically known as tilisolol hydrochloride, (+/-)-, but more generally known as tilisolol hydrochloride, which bears us nih compound identifier 44155. european medicines agency schedules tilisolol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04871mig. most nations, for tariff and trade purposes, schedule tilisolol hydrochloride under hs 29337900 and sitc 51561. as of q4 2014, tilisolol hydrochloride remains us fdas preferred term for this commodity. smiles: cc(c)(c)ncc(coc1cn(c(=o)c2c1cccc2)c)o.cl.. "
